Mood disorders, excluding more controls

KRA_PSY_MOOD_EXMORE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F30-F39 Hospital discharge: ICD-9 — 296\|3004A\|3011D Hospital discharge: ICD-8 — 296\|29800\|3004\|30110 Cause of death: ICD-10 — F30-F39 Cause of death: ICD-9 — 296\|3004A\|3011D Cause of death: ICD-8 — 296\|29800\|3004\|30110 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: KRA_PSY_ANYMENTAL

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	KRA_PSY_MOOD_EXMORE
CONTROL_EXCLUDE	KRA_PSY_ANYMENTAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F3
HD_ICD_9	296\|3004A\|3011D
HD_ICD_8	296\|29800\|3004\|30110
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F3
COD_ICD_9	296\|3004A\|3011D
COD_ICD_8	296\|29800\|3004\|30110
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Mood disorders, excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	69412	46427	22985
Unadjusted period prevalence (%)	14.51	16.48	10.54
Median age at first event (years)	40.82	38.93	44.65

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
60394: Matched controls
354703

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L86

ICPC

Back syndrome with radiating pain

2.2

323.3

3416

9589

U01

ICPC

Dysuria/painful urination

2.0

321.1

4313

13267

IAZ98

NOMESCO Finland

Other internal psychiatric consultation

49.2

319.7

292

Z01

ICPC

Poverty/financial problem

17.5

319.4

376

127

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

+∞

318.6

380

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

120.7

318.6

266

N06DA03

ATC

rivastigmine; oral, transdermal

4.0

318.3

1116

1677

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

317.5

5589

18815

C03CA01

ATC

furosemide; systemic

1.5

316.9

13265

55753

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

+∞

316.9

378

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

316.9

3034

8174

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

315.0

7594

27993

U07

ICPC

Urine symptom/complaint other

1.9

313.2

4401

13751

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

138.9

312.7

259

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

312.6

13875

59009

A11

ICPC

Chest pain NOS

1.9

311.9

4412

13816

30180

ICD-8 Finland

Personality disorders, Immatura

+∞

311.8

372

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

311.7

5197

17192

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

310.3

29319

143182

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

14.4

310.2

395

162

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

2163.9

309.3

372

X15

ICPC

Vaginal symptom/complaint other

2.5

308.6

2278

5444

Z63.5

ICD-10 Finland

Disruption of family by separation and divorce

16.9

308.0

367

128

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

307.8

16054

70470

Z73.9

ICD-10 Finland

Problem related to life-management difficulty, unspecified

6.5

307.7

644

589

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4918.9

307.7

832

N06AA06

ATC

trimipramine; systemic

10.7

307.7

2263

1285

P06

ICPC

Sleep disturbance

3.1

307.7

10260

21768

N05AX08

ATC

risperidone; systemic

29.6

307.7

9041

2100

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

13.0

307.7

1892

879

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

58.8

307.7

4927

535

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

74.1

307.7

463

N03AG01

ATC

valproic acid; systemic, rectal

15.3

307.7

7368

3187

IHZ04, ,

SPAT

12.5

307.7

1831

884

R1250

NOMESCO Finland

Evaluation of functional capability

3.9

307.7

1425

2210

N03AX09

ATC

lamotrigine; oral

24.4

307.7

7282

1984

F43.01

ICD-10 Finland

Acute stress reaction moderate

5.5

307.7

1143

1239

N05AX16

ATC

brexpiprazole; oral

181.9

307.7

400

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

307.7

3100

7839

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

12.0

307.7

1269

634

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

1904.5

307.7

975

A02BC05

ATC

esomeprazole; systemic

1.6

307.7

22399

95578

F61

ICD-10 Finland

Mixed and other personality disorders

83.3

307.7

576

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

333.8

307.7

1006

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

4.4

307.7

1589

2148

J01DA01

ATC

[U] cefalexin

1.5

307.7

34228

164383

L03

ICPC

Low back symptom/complaint

1.9

307.7

18135

66282

ZYC01

NOMESCO Finland

Remote contact by phone

3.8

307.7

4822

8005

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

177.5

307.7

9827

388

R06.0

ICD-10 Finland

Dyspnoea

1.9

307.7

15686

55553

SFA10

NOMESCO Finland

One-surface restoration

1.7

307.7

33118

150290

N05BA01

ATC

diazepam; systemic, rectal

6.1

307.7

12363

14466

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

307.7

4904

13250

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

36.0

307.7

529

Z50.4

ICD-10 Finland

Psychotherapy, not elsewhere classified

26.7

307.7

335

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

30.8

307.7

473

D09

ICPC

Nausea

2.8

307.7

3025

6547

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

5.8

307.7

1044

1079

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

307.7

12895

47262

D19

ICPC

Teeth/gum symptom/complaint

1.5

307.7

17458

76895

F32.9

ICD-10 Finland

Depressive episode, unspecified

44.4

307.7

27376

6507

F32

ICD-10 Finland

Depressive episode

10.1

307.7

7134

4654

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

307.7

10096

39472

F31

ICD-10 Finland

Bipolar affective disorder

209.3

307.7

2032

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

307.7

12293

49105

P74

ICPC

Anxiety disorder/anxiety state

12.0

307.7

5421

2881

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

3099.3

307.7

529

-1, ,

NOMESCO Finland

1.6

307.7

19166

79058

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.4

307.7

3592

9191

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

307.7

25137

102425

SPAT1252

SPAT

Overall medication plan or its review

2.3

307.7

3153

8229

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

1260.1

307.7

1083

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

91.0

307.7

339

SPAT1240

SPAT

Therapeutic discussion

6.7

307.7

11348

11838

P03

ICPC

Feeling depressed

8.9

307.7

13338

10960

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1271.9

307.7

3662

K02.1

ICD-10 Finland

Caries of dentine

1.8

307.7

36512

164118

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

307.7

710

Z03

ICPC

Housing/neighbourhood problem

12.5

307.7

461

218

IBA03

NOMESCO Finland

Psychotherapy evaluation

422.7

307.7

1130

SPAT1235

SPAT

Mental health, emotional support

14.1

307.7

591

249

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

901.0

307.7

2074

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

74.3

307.7

614

S01.0

ICD-10 Finland

Open wound of scalp

2.1

307.7

3790

10860

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

6.3

307.7

718

679

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

9.4

307.7

1460

932

IEY01

NOMESCO Finland

Psychoeducation, individual

261.5

307.7

964

188

Kela drug reimbursment

Psychosis requiring demanding treatment

1688.9

307.7

868

F50.0

ICD-10 Finland

Anorexia nervosa

176.1

307.7

476

F41.3

ICD-10 Finland

Other mixed anxiety disorders

10.6

307.7

1495

851

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

321.5

307.7

1128

F10.09

ICD-10 Finland

Alcohol intoxication UNS

179.1

307.7

1862

F41.8

ICD-10 Finland

Other specified anxiety disorders

7.2

307.7

2962

2530

N05CF02

ATC

zolpidem; oral

3.3

307.7

13590

28504

Z2445

NOMESCO Finland

Psychologist

13.7

307.7

4339

1998

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

307.7

558

SPAT1241

SPAT

Extensive assessment of psychosocial situation

10.9

307.7

1031

566

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

307.7

9017

26636

P28

ICPC

Limited function/disability (P)

30.2

307.7

806

159

N05AD03

ATC

melperone; systemic

23.1

307.7

963

249

D01

ICPC

Abdominal pain/cramps general

2.2

307.7

8005

23035

ICB01, ,

SPAT

13.8

307.7

757

326

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

307.7

2875

7294

J01EA01

ATC

trimethoprim; systemic

1.6

307.7

13227

52991

D10

ICPC

Vomiting

2.5

307.7

3775

9115

P18

ICPC

Medication abuse

42.1

307.7

646

N05AN01

ATC

lithium; oral

150.2

307.7

3901

163

L28

ICPC

Limited function/disability (L)

2.2

307.7

10506

31104

J01FF01

ATC

clindamycin; systemic

1.6

307.7

14366

58745

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

22.0

307.7

1434

391

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

6.0

307.7

1196

1197

F43.0

ICD-10 Finland

Acute stress reaction

2.2

307.7

3301

9032

E66.8

ICD-10 Finland

Other obesity

3.1

307.7

4039

7945

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

8177.4

307.7

1367

ZY000

NOMESCO Finland

Hospital inpatient

55.8

307.7

1520

164

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

38.5

307.7

4163

680

F51.0

ICD-10 Finland

Nonorganic insomnia

3.5

307.7

14164

28184

SPAT1260

SPAT

Consultation of another employee

1.8

307.7

9521

32889

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

41.5

307.7

760

109

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

17.6

307.7

1535

524

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

307.7

17052

65778

N05BA12

ATC

alprazolam; oral

5.9

307.7

9278

10598

F43.8

ICD-10 Finland

Other reactions to severe stress

3.4

307.7

1763

3154

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2035.0

307.7

1714

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.5

307.7

2584

6312

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

307.7

40441

194999

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

11.1

307.7

13008

8538

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

+∞

307.7

679

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

3.3

307.7

2034

3669

P72

ICPC

Schizophrenia

189.1

307.7

1660

U04

ICPC

Incontinence urine

2.5

307.7

2780

6800

R96

ICPC

Asthma

2.0

307.7

5488

17071

K08.3

ICD-10 Finland

Retained dental root

2.3

307.7

4389

11681

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

168.6

307.7

371

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

307.7

3378

8186

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

307.7

13321

48315

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

591.2

307.7

2230

S18

ICPC

Laceration/cut

1.4

307.7

24921

116656

P76

ICPC

Depressive disorder

17.1

307.7

10599

4349

N06BA04

ATC

methylphenidate; oral

13.0

307.7

3333

1586

C07AA05

ATC

propranolol; systemic

3.3

307.7

15915

34286

F10.25

ICD-10 Finland

Alcohol dependence continuous use

91.9

307.7

1851

122

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

668.3

307.7

452

F05.9

ICD-10 Finland

Delirium, unspecified

6.4

307.7

1187

1101

P25

ICPC

Phase of life problem adult

3.6

307.7

3212

5396

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

307.7

14424

52371

TAB00

NOMESCO Finland

Lumbar puncture

2.9

307.7

2476

5234

N05AH03

ATC

olanzapine; systemic

69.4

307.7

9772

984

SPAT1265

SPAT

Breathalyser

16.0

307.7

742

276

F50.1

ICD-10 Finland

Atypical anorexia nervosa

75.1

307.7

419

F50.9

ICD-10 Finland

Eating disorder, unspecified

57.6

307.7

899

A02BC03

ATC

lansoprazole; oral

1.7

307.7

15337

58254

A01

ICPC

Pain general/multiple sites

2.8

307.7

6747

15339

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.1

307.7

3071

6089

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

3.3

307.7

2324

4312

F50.3

ICD-10 Finland

Atypical bulimia nervosa

45.4

307.7

422

SPAT1284

SPAT

Extensive health certificate

3.8

307.7

1745

2784

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

307.7

572

T90

ICPC

Diabetes non-insulin dependent

1.6

307.7

12027

47867

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

430.2

307.7

509

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

307.7

1460

Z91.5

ICD-10 Finland

Personal history of self-harm

164.5

307.7

362

F41.1

ICD-10 Finland

Generalized anxiety disorder

15.8

307.7

6980

2907

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

29.0

307.7

7104

1622

309

Kela drug reimbursment

Nalmefene and naltrexone

26.1

307.7

389

G47.3

ICD-10 Finland

Sleep apnoea

2.0

307.7

14288

48319

N06AB10

ATC

escitalopram; oral

8.9

307.7

25278

26677

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

307.7

17431

63427

Z2446

NOMESCO Finland

Social worker

6.2

307.7

5802

5950

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

307.7

7605

22664

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

314.4

307.7

479

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

307.7

8088

27609

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

+∞

307.7

620

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

129.7

307.7

5282

262

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

391.3

307.7

3277

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

75.3

307.7

4014

335

F45.8

ICD-10 Finland

Other somatoform disorders

2.4

307.7

3827

9828

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

752.7

307.7

2222

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

307.7

704

F41.09

ICD-10 Finland

UNS Panic Syndrome

15.9

307.7

2861

1106

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

+∞

307.7

493

N05AX15

ATC

cariprazine; oral

1106.7

307.7

542

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

44.9

307.7

7474

1113

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

2443.4

307.7

419

D11

ICPC

Diarrhoea

2.3

307.7

7967

21943

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

23.8

307.7

1689

428

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

307.7

1846

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.2

307.7

2803

5385

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

307.7

3815

9055

U02

ICPC

Urinary frequency/urgency

1.7

307.7

7921

28206

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

174.8

307.7

531

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

27.2

307.7

574

125

Z01.2

ICD-10 Finland

Dental examination

1.5

307.7

27361

125567

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

307.7

4777

13173

N06AA09

ATC

amitriptyline; systemic

4.5

307.7

7653

11043

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

8.2

307.7

791

575

ZYY01

NOMESCO Finland

Contact between professionals

70.0

307.7

520

N05AF01

ATC

flupentixol; systemic

16.8

307.7

1484

531

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

+∞

307.7

498

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.2

307.7

8050

12602

SFA30

NOMESCO Finland

Three-surface restoration

1.6

307.7

23921

105175

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

307.7

6161

17916

F39

ICD-10 Finland

Unspecified mood [affective] disorder

40.3

307.7

2705

412

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

307.7

5540

12119

H01

ICPC

Ear pain/earache

1.8

307.7

6908

23464

R52.2

ICD-10 Finland

Other chronic pain

4.0

307.7

2635

3996

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

42.0

307.7

1785

257

M79.7

ICD-10 Finland

Fibromyalgia

5.4

307.7

2956

3338

N05AB03

ATC

perphenazine; systemic, rectal

51.9

307.7

4245

516

G30.1

ICD-10 Finland

Alzheimer disease with late onset

5.4

307.7

1424

1571

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

9.9

307.7

770

462

Z2221

NOMESCO Finland

Medical doctor

1.8

307.7

15429

56790

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

307.7

44309

209414

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

307.7

10919

38923

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

42.3

307.7

606

K04.08

ICD-10 Finland

Other specified pulpit

2.1

307.7

4788

14005

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

2276.1

307.7

777

R4110

NOMESCO Finland

Physiotherapy

1.6

307.7

14692

58702

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

5.7

307.7

1095

1152

IHZ05, ,

SPAT

6.3

307.7

4502

4503

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

825.2

307.7

826

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

307.7

15324

58800

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

10.9

307.7

549

298

P99

ICPC

Psychological disorders other

26.8

307.7

4135

971

F10.20

ICD-10 Finland

Alcohol dependence currently independent

103.5

307.7

2581

153

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

307.7

22865

104398

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

307.7

963

N06BA12

ATC

lisdexamfetamine; oral

18.0

307.7

936

310

Z06

ICPC

Unemployment problem

8.8

307.7

711

477

F43.1

ICD-10 Finland

Post-traumatic stress disorder

17.5

307.7

3021

1067

Z3226

NOMESCO Finland

Physiotherapist

2.0

307.7

10182

31969

M25.5

ICD-10 Finland

Pain in joint

1.6

307.7

18753

79174

B18.2

ICD-10 Finland

Chronic viral hepatitis C

16.7

307.7

884

315

N89

ICPC

Migraine

2.7

307.7

2224

4905

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

307.7

12302

48478

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2660.6

307.7

1347

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

1183.6

307.7

1020

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

12694.9

307.7

2093

ICB03, ,

SPAT

35.8

307.7

388

F93.89

ICD-10 Finland

Other childhood emotional disorders

463.2

307.7

625

C07AB07

ATC

bisoprolol; oral

1.5

307.7

24255

108414

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.8

307.7

2338

5114

R51.80

ICD-10 Finland

Headache

2.5

307.7

11030

28918

P20

ICPC

Memory disturbance

2.4

307.7

5887

15584

SPAT1234

SPAT

Support of social functional capacity

4.7

307.7

3157

4131

N05CD07

ATC

temazepam; oral

5.8

307.7

10124

11974

F90.0

ICD-10 Finland

Disturbance of activity and attention

12.8

307.7

3722

1807

N05BA04

ATC

oxazepam; oral

7.3

307.7

27143

35783

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

307.7

7651

25017

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

1246.7

307.7

433

F03

ICD-10 Finland

Unspecified dementia

8.8

307.7

1431

972

N05AA01

ATC

chlorpromazine; systemic, rectal

105.1

307.7

1262

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

24734

107371

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

307.7

13300

51962

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

307.7

11399

38050

103

Kela drug reimbursment

Diabetes, insulin-treated

1.5

307.7

13103

54015

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

7809.0

307.7

1307

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

80.8

307.7

369

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

307.7

11206

37042

EBA00

NOMESCO Finland

Extraction of tooth

1.8

307.7

22524

86967

P19

ICPC

Drug abuse

18.7

307.7

827

263

N03AX11

ATC

topiramate; oral

5.3

307.7

1842

2107

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

307.7

6537

16666

F29

ICD-10 Finland

Unspecified nonorganic psychosis

462.4

307.7

4652

ZYY79

NOMESCO Finland

Other indirect service without contact with patient

106.7

307.7

415

R21

ICPC

Throat symptom/complaint

1.7

307.7

13150

48897

N03AX16

ATC

[U] pregabalin

2.9

307.7

16381

40566

Z08

ICPC

Social welfare problem

10.7

307.7

1171

652

K59.0

ICD-10 Finland

Constipation

2.6

307.7

3178

7436

IAB11

NOMESCO Finland

Psychiatric mood consultation

36.4

307.7

339

Z29

ICPC

Social problem NOS

5.1

307.7

1475

1745

A02BC02

ATC

pantoprazole; systemic

1.8

307.7

39865

182674

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

78.7

307.7

728

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

174.9

307.7

3455

123

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

307.7

4992

15511

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

307.7

6403

21751

SPAT1254

SPAT

Administration of medicine

2.3

307.7

8392

23656

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

307.7

5365

15470

N05AA02

ATC

levomepromazine; systemic

42.8

307.7

5232

784

EBA30

NOMESCO Finland

Extraction of root of tooth

2.3

307.7

3000

7796

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

108.3

307.7

14353

1018

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

590.7

307.7

499

F41.01

ICD-10 Finland

Severe panic disorder

99.7

307.7

622

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

+∞

307.7

432

N05AL01

ATC

sulpiride; systemic

23.0

307.7

1465

383

N07BA03

ATC

varenicline; oral

2.8

307.7

2983

6523

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.8

307.7

6225

10472

A99

ICPC

Disease/condition unspecnature/site

1.9

307.7

5713

18069

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.6

307.7

1776

2996

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

21.8

307.7

1272

350

Z72.1

ICD-10 Finland

Alcohol use

13.4

307.7

1035

461

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

87.7

307.7

3901

279

N04AA02

ATC

biperiden; systemic

47.9

307.7

1814

229

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

194.2

307.7

751

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

12.1

307.7

676

332

R03BB04

ATC

tiotropium bromide; inhalant

2.0

307.7

4860

14703

P50

ICPC

Psychological, Medication/prescr/renewal

22.5

307.7

354

P80

ICPC

Personality disorder

93.5

307.7

599

N06AX05

ATC

trazodone; oral

19.7

307.7

3036

952

ZY010

NOMESCO Finland

Hospital outpatient

13.0

307.7

6265

3125

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

+∞

307.7

750

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

900.7

307.7

2358

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

307.7

22373

98386

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

307.7

18137

77572

R07.3

ICD-10 Finland

Other chest pain

2.0

307.7

5660

17728

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

1315.1

307.7

456

IGY02, ,

SPAT

25.4

307.7

1856

442

K04.0

ICD-10 Finland

Pulpitis

2.0

307.7

5373

16733

N06AB08

ATC

fluvoxamine; oral

11.8

307.7

2751

1423

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.0

307.7

1765

3558

S29

ICPC

Skin symptom/complaint other

1.7

307.7

11343

43128

N05AX12

ATC

aripiprazole; systemic

259.4

307.7

6505

165

OAB93, ,

SPAT

2.1

307.7

3964

11741

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.9

307.7

4205

6762

R42

ICD-10 Finland

Dizziness and giddiness

1.9

307.7

13234

45088

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

16.4

307.7

13275

5978

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

1392.5

307.7

482

N06AX18

ATC

reboxetine; oral

18.6

307.7

1196

384

H02AB06

ATC

prednisolone; systemic

1.5

307.7

25547

118837

F61.0

ICD-10 Finland

Mixed personality disorders

230.1

307.7

2624

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

4.0

307.7

4190

6510

SPAT1243

SPAT

Psychiatric/psychological examination

8.9

307.7

2516

1733

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

240.7

307.7

1401

IFA99, ,

SPAT

39.9

307.7

412

F43.00

ICD-10 Finland

Acute stress reaction mild

5.4

307.7

1746

1932

R52.1

ICD-10 Finland

Chronic intractable pain

6.8

307.7

656

569

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

+∞

307.7

1014

M54.5

ICD-10 Finland

Low back pain

1.9

307.7

23226

86940

SPAT1216

SPAT

Assessment of functional ability

2.1

307.7

7586

22842

Z3231

NOMESCO Finland

Registered nurse

2.2

307.7

16943

53483

F33.8

ICD-10 Finland

Other recurrent depressive disorders

53.6

307.7

1216

136

X78

ICD-10 Finland

Intentional self-harm by sharp object

3518.0

307.7

599

N05AH04

ATC

quetiapine; oral

20.2

307.7

26030

12802

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

307.7

8353

28827

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

1045.6

307.7

1356

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

307.7

10741

36187

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

307.7

8024

29721

IGV01

NOMESCO Finland

Psychiatric network contact

926.4

307.7

1217

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

307.7

8352

28963

R53

ICD-10 Finland

Malaise and fatigue

2.6

307.7

17745

48994

A02BA02

ATC

ranitidine; systemic

1.8

307.7

9617

33575

N06AA04

ATC

clomipramine; systemic

13.3

307.7

1599

726

ZXY60

NOMESCO Finland

2-person team, nurses

165.2

307.7

585

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

+∞

307.7

450

Z00.0

ICD-10 Finland

General medical examination

1.7

307.7

10490

39643

N06AX22

ATC

agomelatine; oral

23.8

307.7

3252

847

N06AB06

ATC

sertraline; oral

12.7

307.7

15503

9423

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

262.4

307.7

3014

J01DB01

ATC

cefalexin; oral

1.6

307.7

47913

249502

N06DX01

ATC

memantine; oral

4.3

307.7

1788

2504

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

23.6

307.7

822

207

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

307.7

7829

27892

J02AC01

ATC

fluconazole; systemic

1.6

307.7

21797

93949

N05BA06

ATC

lorazepam; systemic, sublingual

9.6

307.7

4844

3206

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

20.1

307.7

4835

1527

XA800

NOMESCO Finland

Neuropsychological investigation

4.3

307.7

2941

4201

AA400

NOMESCO Finland

Electroconvulsive therapy

1121.4

307.7

1159

F31.8

ICD-10 Finland

Other bipolar affective disorders

290.8

307.7

3145

ICB06, ,

NOMESCO Finland

1743.2

307.7

895

N05AX13

ATC

paliperidone; systemic

+∞

307.7

464

N06BA09

ATC

atomoxetine; oral

39.3

307.7

326

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

29.7

307.7

1176

237

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.8

307.7

3798

4932

T82

ICPC

Obesity

3.1

307.7

2943

5839

IFA01, ,

SPAT

34.1

307.7

346

IGY99, ,

SPAT

6.2

307.7

1682

1635

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

472.5

307.7

400

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

6.8

307.7

4571

4208

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

107.5

307.7

759

N03AX12

ATC

[U] gabapentin; oral

2.7

307.7

10844

26299

E66.9

ICD-10 Finland

Obesity, unspecified

2.9

307.7

2198

4626

N05BE01

ATC

buspirone; oral

23.9

307.7

3712

969

L02

ICPC

Back symptom/complaint

2.0

307.7

6266

19068

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

307.7

476

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

120.0

307.7

2880

148

ZXD05

NOMESCO Finland

Urgent procedure

1.5

307.7

15650

65636

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.3

307.7

5151

9879

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

307.7

14926

60766

A97

ICPC

No disease

1.7

307.7

11281

42396

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

307.7

18750

82169

A04

ICPC

Weakness/tiredness general

2.6

307.7

10859

27914

N06AA10

ATC

nortriptyline; systemic

4.8

307.7

1450

1809

N06AX12

ATC

bupropion; oral

16.5

307.7

11281

4866

N05CD02

ATC

nitrazepam; oral

6.5

307.7

1059

972

P29

ICPC

Psychological sympt/compl other

8.4

307.7

8747

7032

N05AE05

ATC

lurasidone; oral

734.0

307.7

496

M79.0

ICD-10 Finland

Rheumatism, unspecified

5.1

307.7

2540

3026

SPAT1283

SPAT

Restricted health certificate

1.9

307.7

10727

36145

R4120

NOMESCO Finland

Occupational therapy

2.2

307.7

3436

9446

N05AF03

ATC

chlorprothixene; systemic

103.9

307.7

3440

206

N17

ICPC

Vertigo/dizziness

1.9

307.7

6783

22278

IAZ99

NOMESCO Finland

Other psychiatric consultation

26.7

307.7

375

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

307.7

23967

85866

SPAT1389

SPAT

Visit based on need for special support

3.8

307.7

1290

2012

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

+∞

307.7

686

R74

ICPC

Upper respiratory infection acute

1.6

307.7

20267

83365

Z02.7

ICD-10 Finland

Issue of medical certificate

2.6

307.7

4636

10906

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

98.5

307.7

11515

846

F33

ICD-10 Finland

Recurrent depressive disorder

16.5

307.7

3058

1143

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

9336.5

307.7

1555

A06AD11

ATC

lactulose; oral

2.7

307.7

8509

20428

F30.0

ICD-10 Finland

Hypomania

141.4

307.7

359

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

267.8

307.7

1075

F41

ICD-10 Finland

Other anxiety disorders

4.8

307.7

1207

1509

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.1

307.7

3758

7331

N03AF02

ATC

oxcarbazepine; oral

3.4

307.7

1929

3378

AA1AD

NOMESCO Finland

CT of head and brain

2.2

307.7

16683

51857

IGY02

NOMESCO Finland

Psychiatric monitoring contact

76.2

307.7

4641

387

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

307.7

7397

24886

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

230.9

307.7

1383

G43.9

ICD-10 Finland

Migraine, unspecified

2.5

307.7

3915

9389

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

14.6

307.7

760

310

T36

ICD-10 Finland

Poisoning by systemic antibiotics

80.5

307.7

6670

546

F84.5

ICD-10 Finland

Asperger syndrome

45.8

307.7

610

SFA20

NOMESCO Finland

Two-surface restoration

1.6

307.7

34658

162427

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

2765.1

307.7

473

Z73.0

ICD-10 Finland

Burn-out

2.6

307.7

2473

5727

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.3

307.7

6135

16588

P01

ICPC

Feeling anxious/nervous/tense

5.6

307.7

13752

17618

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

705.2

307.7

4655

F50.2

ICD-10 Finland

Bulimia nervosa

71.0

307.7

575

N06AX21

ATC

duloxetine; oral

7.3

307.7

13651

13640

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

307.7

21839

92593

IHZ05

NOMESCO Finland

Therapeutic conversation

17.8

307.7

458

152

A03

ICPC

Fever

1.7

307.7

9999

37836

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

172.3

307.7

610

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.0

307.7

5939

18776

IAA01, ,

SPAT

10.0

307.7

712

424

P01AB01

ATC

metronidazole; oral, rectal

1.7

307.7

22685

94646

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

227.0

307.7

2802

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

307.7

13063

47913

V03AA01, ,

ATC

14.8

307.7

1329

540

F41.00

ICD-10 Finland

Moderate panic disorder

68.4

307.7

1765

156

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

307.7

21068

90670

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.3

307.7

3825

5471

SPAT1238

SPAT

Brief therapy

5.1

307.7

1290

1513

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

307.7

14460

59254

KMAK, ,

NOMESCO Finland

1.6

307.7

29447

132545

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

235.3

307.7

1826

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

187.9

307.7

2368

L17

ICPC

Foot/toe symptom/complaint

1.8

307.7

18022

69049

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

89.4

307.7

348

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

63.9

307.7

8312

884

N30.0

ICD-10 Finland

Acute cystitis

1.8

307.7

9450

33220

IAA02

NOMESCO Finland

Consultation concerning further psychiatric treatment

66.8

307.7

317

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

307.7

2675

5775

M01AE02

ATC

naproxen; oral, rectal

1.5

307.7

31678

152749

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

130.8

307.7

508

F34.0

ICD-10 Finland

Cyclothymia

78.6

307.7

478

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

307.7

4294

9738

IER01

NOMESCO Finland

Psychoeducation, group

1213.0

307.7

838

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

90.5

307.7

625

F60.7

ICD-10 Finland

Dependent personality disorder

215.8

307.7

510

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

7.7

307.7

1455

1137

N05AB01

ATC

dixyrazine; systemic

22.1

307.7

1060

286

A05

ICPC

Feeling ill

2.5

307.7

3929

9716

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

307.7

11045

39137

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

8.5

307.7

5715

4289

N06AA12

ATC

doxepin; systemic

8.2

307.7

4878

3782

F60.5

ICD-10 Finland

Anankastic personality disorder

36.5

307.7

1402

231

N06AB05

ATC

paroxetine; oral

9.3

307.7

6670

4673

F32.0

ICD-10 Finland

Mild depressive episode

6.3

307.7

2733

2658

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

307.7

7336

23980

SPAT1263

SPAT

Sampling

1.6

307.7

23135

100377

N06AX16

ATC

venlafaxine; oral

14.3

307.7

21290

13033

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

307.7

8263

21981

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

495.3

307.7

1158

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

122.9

307.7

907

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

307.7

4095

11976

F40.1

ICD-10 Finland

Social phobias

23.2

307.7

3031

807

W19

ICD-10 Finland

Unspecified fall

2.0

307.7

5159

16069

IHZ02, ,

SPAT

5.0

307.7

931

1111

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

307.7

15289

57027

SPAT1229

SPAT

Assessment of need for aid

2.2

307.7

3472

9557

R52.9

ICD-10 Finland

Pain, unspecified

2.1

307.7

6301

18435

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

307.7

25911

110772

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

6.5

307.7

1820

1688

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

54.8

307.7

500

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

71.1

307.7

741

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

307.7

16707

69985

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

46.8

307.7

372

N06AB03

ATC

fluoxetine; oral

9.6

307.7

14789

11579

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

8.6

307.7

1320

916

N05AC01

ATC

periciazine; systemic

30.5

307.7

372

P02

ICPC

Acute stress reaction

2.4

307.7

3432

8538

N05AH02

ATC

clozapine; systemic

1426.5

307.7

1695

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

69.0

307.7

593

F20.0

ICD-10 Finland

Paranoid schizophrenia

2592.2

307.7

444

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

307.7

7945

25357

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

307.7

2698

6127

R11

ICD-10 Finland

Nausea and vomiting

2.6

307.7

5498

13132

Z71.8

ICD-10 Finland

Other specified counselling

1.9

307.7

21463

80350

N04BC05

ATC

pramipexole; oral

2.1

307.7

3807

10767

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

35.3

307.7

471

F21

ICD-10 Finland

Schizotypal disorder

1180.1

307.7

614

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

307.7

18439

67836

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

2780.4

307.7

944

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

108.8

307.7

1833

102

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

55.8

307.7

17684

2612

IEY02

NOMESCO Finland

Intensified psychiatric outpatient care, Assertive Community Treatment (ACT)

491.6

307.7

416

F60.0

ICD-10 Finland

Paranoid personality disorder

379.0

307.7

449

N05CF01

ATC

zopiclone; oral

3.9

307.7

25657

55884

N05AE04

ATC

ziprasidone; systemic

720.0

307.7

727

SPAT1312

SPAT

General health counselling

1.5

307.7

17134

73243

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

13.2

307.7

3714

1755

F34.1

ICD-10 Finland

Dysthymia

56.7

307.7

6579

763

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.0

307.7

2127

2140

M03BX02

ATC

tizanidine; oral

1.5

307.7

35496

170548

N05AD01

ATC

haloperidol; systemic

11.0

307.7

2347

1294

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.1

307.7

3303

4907

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.4

307.7

2455

4414

N02BF02

ATC

pregabalin; oral

3.3

307.7

4955

9451

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

46.3

307.7

4497

615

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

585.4

307.7

4943

R41.0

ICD-10 Finland

Disorientation, unspecified

4.8

307.7

1538

1938

F32.8

ICD-10 Finland

Other depressive episodes

27.7

307.7

2250

495

E0000UV, ,

ATC

1.4

307.7

22709

104728

A29

ICPC

General symptom/complaint other

1.9

307.7

7188

23340

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

307.7

6339

20418

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3018677) aPTT in Platelet poor plasma by Coagulation assay

10401

41410

1.57

317.26

2.2

2.1

29.39

29.63

3.68

10108

40312

(3042936) Bacteria identified in Isolate by Culture

10041

39652

1.58

317.06

2.3

2.0

—

(3044290) Cell count panel - Cerebral spinal fluid

2174

5010

2.61

316.63

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

7009

25247

1.71

316.45

9.5

8.7

122.44

121.49

g/l

3.11

6886

24651

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

56612

314403

1.92

308.56

15.0

11.0

27.75

26.45

u/l

27.10

55453

306165

(3037467) Urinalysis macro (dipstick) panel - Urine

41955

200822

1.74

307.65

5.4

4.2

2.71

3.89

0.33

320

(3013650) Neutrophils [#/volume] in Blood by Automated count

38157

166413

1.94

307.65

11.4

8.9

4.17

4.06

e9/l

15.21

33139

144640

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

4668

14600

1.95

307.65

1.9

1.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

15833

62021

1.68

307.65

2.3

1.9

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

25653

91356

2.13

307.65

3.2

3.7

2.35

mmol/l

1.09

23486

83680

(3002032) Base excess in Venous blood by calculation

7615

24895

1.91

307.65

4.4

3.9

1.80

1.72

mmol/l

0.85

6728

21987

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

15110

53279

1.89

307.65

1.8

1.7

32276688.85

39492586.66

pmol/l

0.70

12771

44738

(3001604) Monocytes [#/volume] in Blood

35020

148451

1.92

307.65

7.3

6.1

0.57

0.58

e9/l

1.68

30118

128595

(40758558) Short blood count panel - Blood

20575

85497

1.63

307.65

7.2

6.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

6754

7618

5.74

307.65

2.0

1.4

0.30

0.26

mg/l

6.77

3341

3353

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3242

8450

2.32

307.65

2.3

537.86

546.52

ug/l

0.04

3054

7983

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

49846

226389

2.68

307.65

5.6

4.1

14.50

14.73

pmol/l

80.82

46653

209070

(3002030) Lymphocytes/Leukocytes in Blood

32383

141287

1.75

307.65

7.4

6.3

28.54

28.15

8.25

30697

134644

(36304419) Bacteria [Presence] in Urine

18627

74528

1.68

307.65

3.6

3.1

48.94

167.93

estimate

0.60

310

(3042517) Benzodiazepines panel - Urine

408

201.04

307.65

2.8

1.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2395

5178

2.79

307.65

1.2

1.3

3.80

3.67

mmol/l

6.83

2262

4926

(3018095) Leukocytes [#/volume] in Urine

25163

106130

1.67

307.65

4.6

3.7

79.95

93.08

e6/l

1.52

17639

73577

(3002582) Erythrocytes [#/volume] in Urine

22192

91007

1.68

307.65

3.8

3.2

47.67

87.53

e6/l

7.25

16931

68825

(3014111) Lactate [Moles/volume] in Serum or Plasma

7245

23253

1.94

307.65

8.2

8.0

1.38

1.30

mmol/l

6.88

7066

22876

(3003396) Base excess in Arterial blood by calculation

8453

29934

1.77

307.65

8.5

7.8

1.06

0.80

mmol/l

6.73

7077

24768

(3019550) Sodium [Moles/volume] in Serum or Plasma

56081

294663

2.65

307.65

23.5

15.8

139.51

139.73

mmol/l

77.95

55316

288683

(3018010) Neutrophils/Leukocytes in Blood

31881

138517

1.75

307.65

7.3

6.2

56.79

57.05

3.61

30463

132985

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

11410

44611

1.62

307.65

3.4

3.0

3.79

2.70

e6/l

8.73

5297

21612

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

12906

51765

1.59

307.65

4.3

3.6

268.18

577.60

ng/l

12.73

9075

39046

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

24013

87793

2.01

307.65

3.2

2.5

57.33

62.99

u/l

3.63

22211

81677

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

52681

283046

1.73

307.65

18.7

13.6

87.14

82.89

ml/min/173m2

307.65

49087

259166

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

31970

116993

2.29

307.65

2.4

2.0

96.90

96.96

pmol/l

0.07

17850

61975

(3022948) Iron [Moles/volume] in Serum or Plasma

12774

47659

1.73

307.65

2.7

2.6

13.19

13.91

umol/l

1.02

11842

44716

(3021589) Normoblasts [#/volume] in Blood

29117

131732

1.58

307.65

12.8

10.7

0.00

e9/l

1.78

23482

108108

(3031040) Bacteria [#/volume] in Urine by Automated count

40879

188725

1.84

307.65

5.8

4.1

1850.03

1364.29

e6/l

0.75

591

2423

(3006315) Basophils [#/volume] in Blood

35119

148780

1.92

307.65

7.4

6.1

0.04

e9/l

1.65

30183

128853

(3021960) Folate [Moles/volume] in Serum or Plasma

22059

70912

2.30

307.65

1.8

1.6

19.90

20.20

nmol/l

2.25

19503

60038

(40768797) Stomach Pathology biopsy report

10032

38978

1.61

307.65

1.3

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

32159

118590

2.27

307.65

7.3

6.5

1.21

mmol/l

0.80

30088

109962

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

12171

42390

1.86

307.65

2.1

1.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

23831

103737

1.58

307.65

4.4

3.3

50.05

61.19

ng/l

0.56

15747

67459

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

8762

28884

1.91

307.65

2.0

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

44213

204931

2.00

307.65

4.6

2.9

50.52

43.93

u/l

34.70

41974

194188

(3012544) pH of Venous blood

7840

26026

1.88

307.65

4.4

4.0

7.38

0.91

4401

15049

(3037522) Nuclear Ab [Titer] in Serum

10876

42003

1.64

307.65

1.4

460.06

553.50

titre

5.76

2068

8983

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

55095

295865

2.07

307.65

20.6

13.7

21.89

23.95

mg/l

40.71

47173

238832

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

22257

81125

1.97

307.65

2.6

2.0

232.49

190.70

u/l

4.36

21131

76676

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2918

7599

2.32

307.65

1.5

1.4

279.48

270.96

ug/g

0.97

1627

4453

(3019977) pH of Arterial blood

8536

30173

1.77

307.65

8.6

7.8

7.41

7.42

6.32

4766

15876

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

15914

27950

4.18

307.65

2.3

1.4

1.56

1.30

287.76

14143

24948

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4516

14049

1.96

307.65

3.5

3.4

1.66

1.69

mmol/l

0.23

3397

10210

(3024354) Oxygen [Partial pressure] in Venous blood

6589

21030

1.94

307.65

3.8

3.2

4.75

4.56

kpa

7.71

6361

20539

(3032080) INR in Blood by Coagulation assay

28308

126719

1.59

307.65

13.2

13.9

1.18

1.24

inr

62.92

23675

105371

(3030467) Casts [#/volume] in Urine by Automated count

19453

78290

1.68

307.65

3.7

3.1

0.35

0.39

e6/l

1.52

14272

56694

(3000850) Epithelial cells [#/volume] in Urine

15617

61996

1.65

307.65

3.0

2.6

6.52

5.33

e6/l

16.70

14217

56295

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

12386

48798

1.62

307.65

3.3

2.9

1.12

1.08

e6/l

0.22

6318

25862

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

35132

134039

2.29

307.65

7.9

7.1

1.21

mmol/l

0.21

30870

115462

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2650

5921

2.70

307.65

1.3

505.35

560.47

mg/l

1.97

2536

5720

(3011288) Drugs identified in Urine by Screen method Nominal

6047

4976

7.82

307.65

3.7

1.3

—

(3019198) Lymphocytes [#/volume] in Blood

35559

152354

1.90

307.65

7.4

6.1

1.98

1.92

e9/l

9.51

31290

135116

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

2403

5136

2.82

307.65

1.4

29.17

39.12

e6/l

0.61

1763

3807

(3016502) Oxygen saturation in Arterial blood

7570

26822

1.75

307.65

8.9

8.2

95.37

95.84

7.86

7363

25896

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

20052

70188

2.01

307.65

2.6

2.3

2.74

2.80

mg/l

2.61

17398

60999

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

9243

30777

1.90

307.65

2.0

1.7

—

(3023183) Ammonium ion [Moles/volume] in Plasma

2396

4085

3.55

307.65

2.9

2.5

33.47

34.24

umol/l

0.55

2183

3695

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

15746

63595

1.61

307.65

2.0

1.7

1.10

1.21

mg/l

3.22

11951

49271

(3021601) Nitrite [Presence] in Urine by Test strip

33224

157279

1.53

307.65

4.5

3.5

0.00

estimate

0.77

7025

32309

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

8264

25414

2.05

307.65

3.0

2.4

41.38

51.83

u/l

0.76

6966

21657

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

1025

517

11.83

307.65

2.6

1.2

158.78

67.03

umol/l

11.68

543

232

(3013115) Eosinophils [#/volume] in Blood

35884

153603

1.92

307.65

7.8

6.2

0.19

e9/l

1.36

31386

135095

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

54187

271252

2.69

307.65

7.1

4.9

1.80

1.89

mu/l

20.66

51449

252935

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

48244

219003

2.46

307.65

9.3

8.0

78.06

u/l

0.00

46134

208501

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

53173

279073

2.00

307.65

5.9

4.7

6.01

5.84

mmol/l

119.95

49857

259431

(3018418) pH of Serum or Plasma

22429

78495

2.08

307.65

4.5

4.4

7.40

0.23

16016

55622

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

14656

50654

1.92

307.65

2.8

3.1

2.44

2.45

mmol/l

7.06

13018

45558

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8523

30143

1.77

307.65

8.6

7.8

5.17

5.07

kpa

17.17

8235

29019

(3033658) Prothrombin time (PT) actual/Normal

17920

71574

1.67

307.65

4.8

3.9

93.12

90.22

44.38

17429

70088

(3013826) Glucose [Moles/volume] in Serum or Plasma

37731

166181

1.89

307.65

6.2

4.7

6.65

mmol/l

0.13

35818

156008

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

9302

32001

1.84

307.65

2.8

2.7

7.30

8.58

umol/l

6.05

7760

28411

(3011397) Hemoglobin [Presence] in Urine by Test strip

16829

69169

1.59

307.65

4.3

3.5

0.39

0.24

0.59

101

660

(3036481) Cortisol [Moles/volume] in Serum or Plasma

9353

24193

2.50

307.65

2.2

2.4

374.88

378.41

nmol/l

0.81

8594

22719

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

35876

146882

2.07

307.65

6.7

6.5

10.21

11.58

umol/l

75.69

33990

140223

(3003458) Phosphate [Moles/volume] in Serum or Plasma

10440

34607

1.93

307.65

6.3

1.04

mmol/l

0.32

9762

32306

(42870588) Differential panel, method unspecified - Blood

24321

96440

1.81

307.65

6.8

6.4

4.80

6.14

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

10253

36069

1.81

307.65

1.8

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

26832

93953

2.22

307.65

3.9

3.1

32.68

32.92

u/l

0.11

25239

89084

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

13518

56216

1.53

307.65

1.4

1.3

30.24

34.44

iu/ml

1.58

3583

17633

(3007164) IgA [Mass/volume] in Serum or Plasma

15841

60207

1.74

307.65

1.5

2.34

2.35

g/l

0.50

9230

39246

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7612

24821

1.92

307.65

2.5

2.3

0.22

0.21

g/l

5.66

6966

23417

(3009466) Valproate [Moles/volume] in Serum or Plasma

3255

1044

19.30

307.65

6.6

2.8

371.33

348.41

umol/l

5.07

2908

872

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

24105

100384

1.68

307.65

3.9

3.3

2.73

1.86

e6/l

0.44

(3044889) 12 lead EKG panel

40786

200122

1.61

307.65

4.4

3.7

5215.96

1324.75

0.45

375

(36660697) Celiac disease serology panel - Serum

6872

23455

1.81

307.65

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

11527

37754

1.98

307.65

2.6

2.0

—

(3022096) Basophils/Leukocytes in Blood

31803

136600

1.78

307.65

7.5

6.4

0.68

0.69

1.95

29841

128624

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

51509

275783

1.66

307.65

7.3

5.8

39.15

38.74

mmol/mol

17.38

48660

260473

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1297

+∞

307.65

15.7

0.0

779.10

—

nmol/l

—

1265

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

32134

127925

2.02

307.65

2.8

2.4

2839.96

77.57

nmol/l

0.50

29647

117220

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

18360

69317

1.80

307.65

1.4

1.3

1.49

1.71

u/ml

1.27

4686

19925

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

5026

14741

2.09

307.65

4.4

4.2

24.30

24.20

mmol/l

1.25

4939

14612

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5246

16756

1.92

307.65

3.7

3.5

5.21

5.10

kpa

17.45

5047

15987

(3023103) Potassium [Moles/volume] in Serum or Plasma

56102

295430

2.62

307.65

23.6

16.0

3.95

3.97

mmol/l

62.48

55264

288890

(3012095) Magnesium [Moles/volume] in Serum or Plasma

13037

44082

1.94

307.65

3.5

0.82

mmol/l

8.34

12247

41687

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5824

17964

2.00

307.65

3.1

3.7

4.44

4.55

pmol/l

10.30

5118

16469

(3009261) Glucose [Presence] in Urine by Test strip

33707

160392

1.53

307.65

4.6

3.6

0.47

0.25

estimate

0.38

6727

31216

(3024561) Albumin [Mass/volume] in Serum or Plasma

31401

121919

2.07

307.65

5.3

5.1

36.18

36.00

g/l

6.49

29488

114679

(3015736) pH of Urine

28613

124627

1.66

307.65

4.0

3.2

6.29

6.19

39.01

15329

71032

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

5928

18875

1.94

307.65

1.8

1.6

—

(4198724) Urine methamphetamine measurement

1239

190

39.08

307.65

2.5

1.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

45641

216442

1.98

307.65

4.9

4.2

11.63

11.18

mm/h

9.37

42955

203807

(3048689) Calprotectin [Mass/mass] in Stool

11052

39023

1.81

307.65

2.4

2.6

119.94

131.69

ug/g

3.03

8659

31503

(3023368) Bacteria identified in Blood by Culture

18697

72745

1.74

307.65

5.0

4.1

—

(3006504) Eosinophils/Leukocytes in Blood

31832

136571

1.78

307.65

7.4

6.3

2.78

2.88

13.11

29891

128756

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6910

22450

1.91

307.65

2.5

2.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

33417

144078

1.81

307.65

3.7

3.0

105.65

120.05

ug/l

17.86

31261

135893

(3019309) Folate [Moles/volume] in Red Blood Cells

14281

36892

2.67

307.65

1.8

1.7

1165.44

1155.44

nmol/l

0.56

11182

28021

(3019150) Specific gravity of Urine by Refractometry

16903

66795

1.68

307.65

4.5

3.7

1.02

1.18

kg/l

2.08

11094

43805

(3021447) Carbon dioxide [Partial pressure] in Venous blood

7844

25508

1.93

307.65

4.4

3.9

5.88

5.80

kpa

9.23

7604

24975

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

10928

40800

1.70

307.65

2.8

2.7

22.07

23.09

11.10

10053

38160

(3029937) Albumin [Presence] in Urine by Test strip

18964

85211

1.45

307.65

4.8

3.7

0.00

0.01

estimate

1.34

6625

29999

(3023511) Choriogonadotropin [Units/volume] in Urine

2271

5148

2.65

307.65

1.5

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

11952

44253

1.73

307.65

2.7

2.6

2.39

2.35

g/l

13.31

10892

41183

(3027801) Oxygen [Partial pressure] in Arterial blood

8522

30127

1.77

307.65

8.6

7.8

11.96

12.88

kpa

44.68

8227

28999

(3024666) Lithium [Moles/volume] in Serum or Plasma

2121

496.52

307.65

13.5

5.5

0.62

0.56

mmol/l

0.77

1974

(3021387) Prolactin [Units/volume] in Serum or Plasma

4086

10523

2.37

307.65

1.7

1.6

357.17

265.87

mu/l

26.16

3651

9636

(3035350) Ketones [Presence] in Urine by Test strip

33635

159067

1.55

307.65

4.5

3.6

5.31

3.17

estimate

1.33

7127

32894

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

10783

34376

2.03

307.65

2.5

2.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2428

5208

2.81

307.65

1.4

1.5

2556.72

2172.11

e6/l

0.09

1891

4125

(3020564) Creatinine [Moles/volume] in Serum or Plasma

56898

315270

2.04

307.65

25.3

17.7

75.11

76.86

umol/l

25.29

56403

311800

(3026782) Osmolality of Urine

13671

51749

1.71

307.65

3.1

2.8

508.00

542.52

mosm/kgh2o

47.06

11941

45481

(3019069) Monocytes/Leukocytes in Blood

31921

136902

1.78

307.65

7.5

6.4

8.55

8.83

59.15

29990

129162

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

5895

18538

1.96

307.65

2.3

1.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1654

205

48.69

307.65

2.1

1.3

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1425

985

8.68

307.65

1.7

1.1

1.45

0.74

promille

34.79

1101

806

(3009508) Creatinine [Moles/volume] in Urine

23752

98029

1.70

307.65

3.8

3.4

7.69

7.82

mmol/l

3.33

20312

83827

(3009343) pH of Capillary blood

5100

16282

1.92

307.65

3.7

3.5

7.41

7.42

10.30

4317

13425

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

12444

51952

1.51

305.09

1.4

1.3

9.11

11.16

u/ml

2.22

4457

21323

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

17584

78779

1.44

301.38

3.2

3.1

1073.73

1310.55

ng/l

10.01

14625

67633

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

4403

14048

1.91

294.06

1.1

15.29

5.97

u/ml

0.50

177

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5212

17576

1.81

293.19

8.6

8.3

24.96

24.69

mmol/l

5.40

5163

17469

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2810

7599

2.23

290.32

2.1

1.7

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1522

3074

2.96

281.14

1.6

1.7

404.00

347.08

mu/l

2.60

1196

2545

(3020779) Urea [Moles/volume] in Serum or Plasma

6555

23962

1.68

277.85

8.1

7.8

8.73

10.00

mmol/l

37.71

6276

22977

(3013512) EKG study

20259

94341

1.39

272.22

3.8

3.4

0.71

0.74

0.19

221

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

12537

53551

1.47

269.86

1.8

1.7

—

(3000494) Fungus identified in Specimen by Culture

8802

34861

1.57

269.72

1.6

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

699

811

5.11

267.79

1.0

33.73

32.04

ng/l

0.49

508

536

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

696

809

5.10

266.14

1.0

833.80

860.11

ng/l

0.50

505

518

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

695

809

5.09

265.36

1.0

250.02

326.80

ng/l

0.92

517

544

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7819

30262

1.59

263.68

7.9

6.2

—

(3003181) Sodium [Moles/volume] in Urine

1734

3941

2.63

258.80

1.5

1.4

58.42

63.67

mmol/l

4.78

1321

3192

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

4077

13242

1.87

256.66

3.6

2.8

1.51

1.16

46.56

4062

13179

(3009214) Lutropin [Units/volume] in Serum or Plasma

3081

9154

2.03

250.36

1.5

1.4

9.36

9.86

u/l

1.12

2400

7570

(3023323) Follitropin [Units/volume] in Serum or Plasma

4721

16203

1.77

248.60

1.5

1.3

23.58

27.31

iu/l

11.75

3864

14136

(3005719) IgG [Mass/volume] in Serum or Plasma

6030

22183

1.66

247.68

2.6

2.9

10.33

10.68

g/l

8.10

5507

20616

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

5594

20178

1.69

247.28

4.0

4.1

88.33

90.33

ng/l

0.69

4845

17684

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

4025

13176

1.85

246.97

3.6

2.8

0.61

0.62

0.45

4014

13133

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3850

12475

1.87

243.70

2.5

2.3

5490.01

6324.02

u/l

0.77

1255

5426

(3027945) Reticulocytes/Erythrocytes in Blood

7807

30772

1.56

241.77

2.6

1.81

1.75

5.96

6883

27733

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4594

15775

1.77

241.18

10.2

10.0

24.35

24.22

mmol/l

1.68

4465

15476

(3019060) Gas panel - Arterial blood

4357

14732

1.79

240.79

5.2

4.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

5887

21701

1.66

239.43

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5810

21408

1.66

236.51

1.2

116.87

148.00

u/ml

6.34

1966

8502

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4907

17290

1.73

235.40

10.6

9.9

1.47

1.25

29.90

4888

17193

(3014007) Fractional oxyhemoglobin in Arterial blood

4912

17412

1.71

230.42

10.7

10.0

93.51

94.20

10.66

4900

17365

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4767

16763

1.73

230.06

10.9

10.2

0.64

0.63

0.12

4748

16685

(3004119) Hemoglobin [Mass/volume] in Venous blood

4558

15825

1.75

229.97

3.7

3.3

130.41

129.71

g/l

1.20

4420

15404

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

875

1405

3.70

228.54

1.8

1.2

—

(3020891) Body temperature

3570

11535

1.87

227.43

5.4

4.1

36.94

36.89

°c

10.86

3536

11433

(3008295) Osmolality of Serum or Plasma

1157

2252

3.06

226.98

1.7

1.4

281.13

278.83

mosm/kgh2o

2.04

845

1771

(21494755) Public health laboratory ask at order entry panel

3810

37126

0.58

219.48

1.3

—

(3023410) Appearance of Cerebral spinal fluid

1153

2299

2.98

217.33

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

15625

71842

1.37

214.16

2.6

2.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

46661

252199

1.38

212.41

25.3

16.5

13.61

13.52

50.04

46191

248739

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1455

3353

2.59

211.07

1.6

1.4

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

238

18.71

207.37

1.6

1.0

1.00

—

mmol/l

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

237

18.63

206.19

1.6

1.0

1.99

—

mmol/l

—

(3019225) pH of Specimen

6373

24834

1.57

204.71

4.3

4.1

7.36

7.35

1.57

4857

17533

(3014765) Yersinia sp identified in Stool by Organism specific culture

2453

7241

2.03

201.92

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2442

7202

2.03

201.49

1.2

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4373

15561

1.70

201.07

8.0

6.5

24.75

24.46

mmol/l

4.92

4235

14853

(42529406) Shigella sp [Presence] in Stool by Culture

2450

7267

2.02

199.02

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2845

8922

1.92

197.49

3.0

2.9

24.84

24.56

mmol/l

3.29

2790

8774

(3012516) Albumin [Mass/volume] in Urine

19308

92604

1.33

197.11

3.7

3.5

47.99

47.42

mg/l

0.11

12454

58873

(3020682) Albumin/Creatinine [Ratio] in Urine

19565

94080

1.33

195.85

4.4

4.2

9.48

8.06

mg/mmol

2.76

12248

58713

(3003327) Ova and parasites identified in Stool by Light microscopy

3253

10690

1.83

195.73

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3098

10087

1.85

191.80

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1652

4260

2.31

189.25

1.4

1.3

23.54

27.25

u/l

4.08

1280

3599

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2796

8879

1.89

186.76

3.8

3.6

24.84

24.77

mmol/l

0.65

2627

8174

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4373

15933

1.66

183.43

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

5444

20953

1.58

183.11

2.5

2.2

6.68

7.63

ug/l

1.89

4618

18732

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2355

7149

1.97

179.15

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

4638

17282

1.62

178.00

1.9

2.0

1.26

1.29

g/l

0.56

4253

16015

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

24208

121257

1.29

172.74

4.5

3.5

0.86

0.44

estimate

0.92

5816

26737

(3007566) Smooth muscle Ab [Titer] in Serum

2529

8019

1.89

169.36

1.2

1.3

94.44

129.26

titre

1.89

250

759

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

27648

141081

1.28

168.99

3.0

2.7

—

estimate

—

(3018405) Lactate [Moles/volume] in Arterial blood

2461

7739

1.90

168.93

4.6

3.8

1.40

1.36

mmol/l

1.00

2433

7584

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

225

103

12.87

168.08

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

5349

20893

1.55

167.96

4.3

3.9

1.23

mmol/l

1.21

4575

18095

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1719

4742

2.16

167.95

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1718

4741

2.16

167.70

1.4

1.3

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

679

1137

3.54

167.34

1.9

1.3

2193257.63

1830110.22

iu/ml

0.20

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

4812

41815

0.65

165.55

1.8

1.9

3.54

3.50

ratio

1.18

3542

31854

(3019832) Treponema pallidum Ab [Presence] in Serum

8369

35908

1.43

165.42

2.0

1.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2483

7893

1.88

164.94

1.3

—

(3025941) Bacteria identified in Stool by Culture

4329

16162

1.62

164.27

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

2119

6388

1.98

164.15

3.5

3.4

62.84

62.68

0.11

2007

6235

(3052851) Hemolysis interference index of Serum or Plasma

2290

7122

1.92

162.29

3.2

3.1

1.85

2.20

index

1.30

1201

3532

(3017732) Neutrophils [#/volume] in Blood

8614

37325

1.41

160.72

3.6

2.8

4.53

4.42

e9/l

0.48

7397

32693

(3023520) Reticulocytes [#/volume] in Blood

5874

23695

1.51

158.57

2.5

2.7

72.43

69.00

e9/l

8.51

4177

17480

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

24841

125765

1.27

157.60

2.0

1.9

1.52

1.33

mmol/l

143.74

21177

106536

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5213

20535

1.54

157.02

2.4

20.56

21.26

au/ml

0.23

464

2617

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3246

11368

1.72

156.71

1.3

1.2

0.41

0.98

u/ml

4.05

261

865

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3511

12568

1.68

156.51

4.6

3.8

50.81

47.15

13.53

3450

12403

(3013139) Helicobacter pylori Ag [Presence] in Stool

5170

20350

1.54

156.23

1.3

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

2454

7932

1.85

154.71

1.2

678.12

992.53

titre

1.32

241

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4850

18967

1.55

150.60

1.3

47.40

53.10

au/ml

0.92

223

1289

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2356

7625

1.85

147.83

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

5545

22452

1.50

146.29

2.3

2.8

66.58

66.54

g/l

0.15

5056

20800

(3014051) Protein [Presence] in Urine by Test strip

17879

87504

1.28

145.49

3.2

2.7

0.12

0.05

1.11

283

1765

(1616796) Gas panel - Central venous blood

1871

5672

1.97

142.44

3.9

3.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1645

4757

2.06

142.39

1.1

—

(3045414) Leukocytes [Presence] in Urine

6557

27584

1.44

142.29

2.2

2.0

0.02

0.03

estimate

0.33

1360

5816

(3028626) Oxygen [Partial pressure] in Capillary blood

2046

6427

1.90

140.50

3.1

8.40

8.33

kpa

0.88

2001

6267

(3043409) Potassium [Moles/volume] in Arterial blood

2058

6504

1.89

138.76

5.0

4.1

3.84

3.89

mmol/l

5.41

2050

6447

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

995

2367

2.49

135.25

1.6

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

901

2039

2.62

135.21

1.9

2.3

19.29

18.59

nmol/l

1.20

838

1961

(3017181) Myelocytes/Leukocytes in Blood

6201

26046

1.44

135.17

4.6

4.4

0.85

0.97

2.40

1859

7587

(3010421) pH of Blood

2412

8125

1.77

132.73

4.2

3.3

7.41

4.33

2366

8029

(3025159) Blasts/Leukocytes in Blood

6023

25246

1.45

132.57

4.9

4.6

0.08

0.36

6.24

1517

6373

(3002179) Metamyelocytes/Leukocytes in Blood

5935

24810

1.45

132.50

4.3

0.62

0.71

1.72

1788

7236

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1250

3333

2.23

132.33

2.1

1.8

4078.71

3074.89

titre

0.33

133

(3005322) IgE [Units/volume] in Serum or Plasma

5032

20367

1.49

132.25

1.4

1.3

278.59

226.83

u/ml

1.01

4644

19075

(3020961) Endomysium IgA Ab [Titer] in Serum

3829

14617

1.57

131.33

1.1

173.46

186.99

titre

0.11

449

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

53265

299165

1.39

131.24

6.2

5.4

2.73

2.75

mmol/l

4.21

50113

282167

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

3558

31504

0.64

131.00

1.6

3.48

mmol/l

0.03

2355

21340

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4022

15539

1.56

130.97

10.8

10.1

16.12

16.16

0.31

3909

14990

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1597

4784

1.99

125.56

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

3015

10970

1.65

125.55

1.7

4.03

4.26

mg/l

0.53

2527

7633

(3035637) Corticotropin [Mass/volume] in Plasma

1257

3438

2.17

125.19

1.6

27.94

36.11

ng/l

2.67

1251

3432

(3004716) Salmonella sp identified in Stool by Organism specific culture

3824

14788

1.55

123.74

1.3

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

1703

5265

1.93

122.39

4.5

3.6

8.78

8.71

kpa

0.78

1655

5159

(3021440) Promyelocytes/Leukocytes in Blood

5906

25010

1.43

122.38

4.7

4.4

0.10

0.12

1.04

1565

6589

(3012501) Base excess in Blood by calculation

1693

5225

1.93

122.29

4.5

3.6

2.45

2.44

mmol/l

0.01

1192

3471

(3013290) Carbon dioxide [Partial pressure] in Blood

1693

5227

1.93

122.15

4.5

3.6

5.08

4.96

kpa

7.80

1645

5121

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

1042

2661

2.32

121.76

1.1

84.40

65.83

au/ml

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

3086

11389

1.62

121.41

4.0

3.4

25.37

25.24

mmol/l

1.18

2961

11026

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2258

7695

1.75

119.26

2.2

1.8

193.49

204.64

pmol/l

4.32

2120

7377

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

169

11.31

118.36

1.1

50.80

37.12

mg/l

2.25

(3026493) Urate [Moles/volume] in Serum or Plasma

16026

78945

1.26

117.70

2.7

333.80

341.04

umol/l

15.08

13963

70919

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

7287

55716

0.74

116.86

2.9

3.2

0.65

0.79

ug/l

18.86

4856

34422

(3004588) Protein electrophoresis panel - Serum or Plasma

4429

17890

1.49

116.86

2.2

2.5

—

2.00

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

7455

33151

1.37

115.50

3.9

4.8

231.05

244.29

u/l

11.90

7014

31724

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1284

14356

0.51

115.43

1.1

0.63

ratio

0.11

155

1655

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2838

10399

1.63

114.72

2.1

1.8

39.21

41.11

nmol/l

3.06

2769

10217

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

50102

279969

1.30

113.03

4.6

4.1

1.43

1.26

mmol/l

307.65

46528

262052

(3021901) Oxygen saturation in Capillary blood

1685

5336

1.88

112.68

3.0

90.71

90.45

0.89

1642

5187

(3022145) Colonoscopy Study observation

7695

34583

1.35

111.01

1.4

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

52592

296062

1.34

110.25

5.5

4.8

4.63

4.67

mmol/l

18.98

49650

280404

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

6253

27228

1.39

109.70

4.2

3.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2991

11261

1.59

108.14

1.6

1.7

16.28

15.48

u/ml

0.19

549

3112

(3019230) Fractional oxyhemoglobin in Venous blood

1727

5615

1.83

106.39

3.5

3.1

62.28

63.36

1.14

1719

5598

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

10088

72985

0.77

106.38

4.1

4.4

21.40

22.13

4.49

4175

34800

(3023420) DNA double strand Ab [Units/volume] in Serum

3265

12602

1.55

106.03

1.9

1.8

7.12

7.37

iu/ml

0.15

732

2964

(3007461) Platelets [#/volume] in Blood

57389

328263

1.54

105.81

32.1

20.6

259.95

251.88

e9/l

155.79

56527

321781

(3016038) Potassium [Moles/volume] in Urine

660

1443

2.70

105.77

1.3

1.2

31.42

35.14

mmol/l

3.50

564

1277

(3017446) Testosterone [Moles/volume] in Serum or Plasma

6108

26689

1.38

104.61

2.8

2.2

12.50

13.21

nmol/l

8.75

5429

24577

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1497

15508

0.56

103.58

1.2

1.1

0.89

g/l

0.05

1491

15464

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

38.43

103.02

1.7

1.0

240.06

126.71

nmol/l

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2472

8986

1.64

102.88

1.8

1.7

0.24

0.23

g/l

0.71

2350

8598

(3024731) MCV [Entitic mean volume] in Red Blood Cells

57392

328429

1.53

102.85

32.0

20.5

90.87

90.73

10.12

56956

325367

(3035941) MCH [Entitic mass]

57391

328427

1.53

102.75

31.9

20.4

30.26

30.25

0.29

56957

325374

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2529

9254

1.63

102.56

1.8

1.7

1.21

1.18

g/l

5.24

2413

8887

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

57392

328447

1.53

102.48

32.7

20.9

40.49

41.28

9.39

56949

325234

(3026361) Erythrocytes [#/volume] in Blood

57391

328476

1.53

101.75

32.0

20.5

4.49

4.53

e12/l

73.70

56384

320972

(3010813) Leukocytes [#/volume] in Blood

57398

328525

1.53

101.75

32.1

20.6

6.93

6.64

e9/l

137.86

56417

320996

(3017509) Phencyclidine [Presence] in Urine

214

198

6.37

101.49

2.2

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

52267

294612

1.31

100.45

5.4

4.7

1.40

1.47

mmol/l

243.96

49070

277620

(3000963) Hemoglobin [Mass/volume] in Blood

57393

328571

1.52

100.12

32.3

20.7

134.94

136.38

g/l

105.60

56964

325575

(40767503) Oxygen content in Capillary blood by calculation

1647

5387

1.82

99.49

2.9

2.5

16.78

16.64

0.93

1608

5270

(3028271) Lactate [Moles/volume] in Capillary blood

1267

3809

1.97

98.53

2.2

1.7

1.72

1.69

mmol/l

0.42

1236

3699

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1016

2812

2.14

98.26

1.3

1.2

35.07

34.23

nmol/l

0.03

(3016244) Insulin [Units/volume] in Serum or Plasma

708

1674

2.50

97.50

3.1

30.15

24.48

mu/l

2.75

662

1586

(3030981) Hyaline casts [#/volume] in Urine by Automated count

5345

23095

1.39

97.42

2.7

2.4

0.39

0.38

e6/l

0.13

5107

22055

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

2710

10215

1.58

97.27

2.1

1.9

1.98

2.33

ug/l

0.77

2415

9158

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

841

2170

2.29

96.04

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

455

848

3.17

95.79

1.4

1.5

555.01

753.44

mu/l

0.71

425

816

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

842

2181

2.29

95.32

1.2

37.68

48.08

mg/l

5.87

719

1842

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

459

864

3.14

95.13

1.4

1.5

73.74

72.95

0.51

429

832

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1518

4978

1.81

90.89

1.5

1.4

0.36

0.42

nmol/l

1.37

1162

3851

(3048929) Epstein Barr virus Ab [Presence] in Serum

2724

10441

1.56

90.88

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

808

2108

2.27

90.00

1.1

246.61

283.47

mg/l

3.26

712

1882

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2482

9374

1.58

88.19

2.3

2.6

0.66

0.80

g/l

1.17

2148

8135

(3008898) HLA-B27 [Presence]

2813

10937

1.54

88.01

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3144

12524

1.50

87.86

1.8

1.53

1.51

g/l

0.60

2734

10794

(4027681) Cerebrospinal fluid IgG ratio and IgG index

662

1597

2.45

87.52

1.2

1.3

0.62

0.64

ratio

0.39

387

907

(3036489) Thrombin time

2857

11166

1.53

87.28

2.1

20.73

21.02

1.45

2520

9800

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2092

7643

1.63

85.13

2.2

2.4

0.00

g/l

0.02

1824

6747

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2409

9125

1.57

84.48

1.3

36.05

40.36

u/ml

0.25

103

513

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3162

12728

1.48

83.89

1.9

2.1

40.08

39.72

u/l

0.42

2834

11460

(3029634) Reagin Ab [Titer] in Serum by VDRL

1311

4223

1.84

83.07

2.5

2.2

7.81

6.86

titre

0.14

118

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2219

8279

1.60

82.91

2.0

8.04

16.22

iu/l

0.55

867

3466

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

761

2005

2.24

82.89

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2156

7998

1.60

82.48

2.2

2.4

0.02

0.03

g/l

0.20

1943

7248

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1834

6542

1.67

81.84

2.3

2.2

132.12

130.68

g/l

1.55

1420

4998

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

29.77

80.76

1.8

1.2

249.40

169.78

nmol/l

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

374

689

3.20

80.27

3.0

2.9

29.41

28.01

umol/l

0.98

265

546

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2645

10352

1.52

80.15

2.1

2.4

2.87

2.89

g/l

0.31

2401

9488

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1097

3381

1.92

79.45

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2917

11692

1.49

78.91

5.7

4.7

1.82

1.57

20.03

2774

11080

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1952

7145

1.62

78.78

2.3

2.5

0.00

g/l

-0.00

1817

6736

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

745

1995

2.21

78.13

1.3

1.2

2.06

2.12

mmol/l

0.58

692

1865

(3026389) Candida sp identified in Specimen by Organism specific culture

1272

4140

1.82

78.00

1.4

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2756

10980

1.50

76.73

2.1

2.4

7.34

7.35

g/l

0.09

2513

10113

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2752

10968

1.50

76.48

2.1

2.4

4.24

4.21

g/l

1.08

2512

10111

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2743

10953

1.49

75.51

2.1

2.4

3.72

3.71

g/l

0.10

2507

10087

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2418

9407

1.53

75.23

2.1

2.4

9.78

10.23

g/l

5.35

2149

8460

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

558

1334

2.47

75.23

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1554

5433

1.70

74.67

1.8

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2639

10491

1.50

74.20

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3012

12297

1.46

74.20

1.5

1.6

11.19

14.64

iu/ml

0.60

353

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1839

6739

1.62

73.85

1.2

44.16

46.27

u/ml

0.17

141

626

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

626

1594

2.32

73.74

1.4

1.3

5.00

5.20

umol/l

0.58

554

1431

(3045716) Anion gap in Serum or Plasma by calculation

874

2554

2.02

73.51

3.4

3.0

10.52

10.69

mmol/l

0.56

859

2522

(3022806) Fractional oxyhemoglobin in Capillary blood

968

2941

1.95

73.08

2.1

1.6

89.81

90.16

1.02

952

2896

(3045424) Erythrocytes [Presence] in Urine

3390

14196

1.43

72.95

2.2

2.1

0.02

0.15

estimate

0.96

1092

4600

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1110

3546

1.85

72.19

6.8

6.0

11.44

11.62

mg/l

0.62

1029

3302

(3037121) Protein [Mass/volume] in Urine

2380

9323

1.52

71.70

3.4

3.3

497.57

526.13

mg/l

0.09

1085

4411

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1209

3979

1.80

71.52

1.3

0.14

0.28

nmol/l

2.95

232

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1917

7157

1.59

71.32

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

426

912

2.76

71.13

2.9

2.3

54.25

48.86

umol/l

2.53

360

806

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1868

6937

1.60

71.05

1.6

—

(3047181) Lactate [Moles/volume] in Blood

2052

7800

1.56

70.73

6.4

5.4

1.36

1.26

mmol/l

3.54

1831

6916

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

757

2127

2.10

70.57

1.1

675.48

290.37

mg/l

0.50

687

1960

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

592

1503

2.33

70.22

1.1

2.33

7.02

nmol/l

2.42

101

295

(3011648) Oxygen content in Venous blood

900

2712

1.96

69.57

2.2

2.6

11.02

11.07

0.10

894

2698

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

13387

90552

0.83

68.82

4.8

5.4

2.19

2.96

ug/l

4.22

11979

82937

(3040151) Glucose [Moles/volume] in Capillary blood

927

2834

1.94

68.77

8.6

5.0

7.51

7.14

mmol/l

1.14

764

2342

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2488

9928

1.49

68.61

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1558

5584

1.66

68.21

2.7

2.0

0.92

0.85

nmol/l

2.90

1304

4794

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

878

2645

1.96

67.93

1.4

1.3

1.51

1.44

nmol/l

0.92

800

2386

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1182

3928

1.78

67.74

1.3

1.67

1.70

nmol/l

0.01

1137

3804

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

500

1195

2.47

67.51

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2584

10459

1.47

66.37

2.2

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1410

4966

1.68

65.93

1.5

1.6

0.69

0.79

g/l

3.07

1098

3859

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2386

9522

1.49

65.72

2.1

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2197

8622

1.52

65.55

1.3

6.63

6.23

u/ml

0.07

152

853

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

389

829

2.77

65.54

1.4

13.31

15.29

pmol/l

7.06

313

717

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2193

8605

1.52

65.47

1.3

6.88

8.77

u/ml

0.59

243

1291

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

492

1185

2.45

65.40

1.2

59.41

67.72

0.80

162

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1734

6453

1.60

65.35

1.3

51.87

41.13

u/ml

0.23

108

(3013005) Retinol [Moles/volume] in Serum or Plasma

482

1152

2.47

65.10

1.8

1.7

1.95

1.99

umol/l

0.43

439

1047

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1640

6035

1.61

64.71

1.3

263.40

250.08

u/ml

1.01

1069

3823

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

+∞

63.64

2.0

0.0

249.78

—

ug/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

17092

88976

1.18

62.22

3.8

3.0

0.28

0.22

estimate

0.23

5778

25957

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

673

1899

2.09

62.12

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

4517

20330

1.33

62.08

3.0

2.9

150.27

196.21

ng/l

10.49

4062

18597

(3006922) Hepatitis E virus Ab [Presence] in Serum

763

2258

2.00

62.07

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1032

3380

1.81

62.05

1.3

0.18

0.28

nmol/l

0.71

757

2674

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

665

1880

2.09

61.09

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

328

666

2.90

60.22

1.4

—

(3003129) Base excess in Capillary blood by calculation

961

3117

1.82

59.63

2.2

2.1

0.83

0.33

mmol/l

3.87

919

2994

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1693

6406

1.57

59.46

1.5

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

456

1109

2.43

59.45

2.2

2.1

17.39

28.99

umol/l

1.06

(40761536) Microorganisms panel - Urine sediment

5164

23817

1.30

59.41

4.7

3.6

—

(4024509) Urine culture

2966

12578

1.40

59.16

2.1

1.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1864

7219

1.53

59.06

1.2

1.3

3.04

5.49

u/ml

1.08

517

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

567

1529

2.19

58.60

1.1

1.09

1.13

u/l

0.38

211

643

(3012920) Ethanol [Mass/volume] in Serum or Plasma

28.90

58.40

1.5

1.1

2.06

2.04

g/l

0.02

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1059

3562

1.76

58.31

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2203

8864

1.48

58.20

2.5

188.13

189.24

0.22

2092

8443

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

447

1089

2.42

58.08

1.8

1.7

28.00

29.25

umol/l

1.62

422

1015

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1913

7486

1.52

57.78

1.3

15.95

16.05

u/ml

0.00

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1056

3570

1.75

57.15

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

565

1544

2.16

56.56

1.5

5.86

6.23

u/l

0.23

468

1325

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1159

4039

1.70

56.35

1.1

1.50

1.49

g/l

0.11

1055

3731

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

484

1244

2.30

55.97

1.9

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2340

9599

1.45

55.97

2.3

2.2

94.52

93.43

1.35

2257

9241

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2042

8155

1.49

55.96

1.5

16.31

13.50

iu/ml

0.26

203

(3007930) Methemoglobin/Hemoglobin.total in Blood

2569

10724

1.43

55.94

6.2

4.9

0.88

0.15

2441

10138

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

498

1298

2.26

55.79

1.6

13.98

5.89

nmol/l

0.34

405

1079

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1988

7910

1.49

55.47

1.9

1.7

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1651

6314

1.55

55.34

1.5

1.4

20.94

22.76

u/ml

0.15

120

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1664

6377

1.55

55.26

1.5

1.4

—

(3011985) Renin [Units/volume] in Plasma

1190

4210

1.67

54.74

1.6

68.00

57.88

mu/l

0.69

1060

3823

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2265

9274

1.45

54.70

2.8

2.5

3.59

3.61

g/l

0.32

2176

8913

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

323

688

2.77

54.58

1.4

1.2

128.22

129.16

nmol/l

0.03

217

523

(3039443) Prostate specific Ag panel - Serum or Plasma

484

5840

0.48

54.51

1.5

1.6

—

20.58

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

63.85

54.49

1.4

1.0

142.55

120.71

nmol/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

391

924

2.49

54.15

1.5

1.4

170.83

214.61

nmol/24h

0.21

391

924

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1025

3496

1.73

53.82

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

985

3326

1.75

53.55

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

982

3315

1.75

53.44

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

985

3333

1.75

53.17

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1023

3501

1.73

53.09

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2245

9238

1.44

52.79

2.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

483

1288

2.21

51.35

1.3

1.2

276.89

352.80

u/l

0.80

443

1200

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

374

888

2.48

51.34

1.9

2.6

0.99

1.04

ug/l

0.18

347

849

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

639

1902

1.98

51.25

1.1

—

0.27

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1412

5302

1.58

51.24

1.5

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

538

1507

2.11

50.70

1.6

1.4

18.94

25.65

umol/l

6.33

492

1399

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2013

8179

1.46

50.56

1.1

3.87

5.43

eliau/ml

1.08

210

1176

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1522

5836

1.55

50.42

1.5

143.25

150.79

au/ml

1.51

434

1683

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6966

34002

1.23

49.04

5.1

4.8

30.73

32.50

32.91

5072

23365

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1090

3885

1.66

48.78

1.4

348.05

366.92

pmol/l

0.19

940

3360

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

4978

23412

1.27

48.64

2.8

2.6

70.75

67.12

ml/min/173m2

7.45

2185

9661

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

372

912

2.40

47.81

2.6

2.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2548

10918

1.39

47.66

1.3

217.80

223.75

miu/ml

0.31

978

5413

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

326

751

2.56

47.60

1.2

21.50

20.45

0.07

148

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1402

5367

1.55

46.80

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

336

793

2.50

46.75

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

16.46

46.66

1.2

1.0

—

mmol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1261

4724

1.58

46.23

1.1

838.78

551.18

iu/ml

0.14

263

983

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1970

8122

1.44

45.81

1.2

1.1

—

(4062490) Immunoglobulin typing, IgG

872

2999

1.72

44.54

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1248

4706

1.57

44.50

1.7

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1137

4217

1.59

43.49

1.2

19.58

18.02

u/ml

0.08

177

(3024139) IgG subclass 3 [Mass/volume] in Serum

879

3053

1.70

43.35

1.4

0.38

0.42

g/l

1.85

635

2178

(3028192) IgG subclass 2 [Mass/volume] in Serum

879

3054

1.70

43.30

1.4

2.90

3.01

g/l

0.95

632

2181

(3001186) Copper [Moles/volume] in Serum or Plasma

298

689

2.55

43.26

1.3

16.91

16.57

umol/l

0.48

256

591

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

604

1873

1.90

43.17

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

879

3057

1.70

43.15

1.4

6.43

6.85

g/l

2.59

633

2180

(3014271) Vancomycin [Susceptibility]

357

902

2.33

43.05

3.2

2.7

—

(3025130) Human papilloma virus identified in Specimen

1289

4938

1.54

42.91

1.8

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1196

4511

1.57

42.62

1.3

—

18.82

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1953

8184

1.41

41.53

2.0

2.2

11.56

11.34

mg/l

0.50

1827

7716

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

893

3154

1.67

41.43

2.2

2.0

21.23

26.78

mg/l

3.02

329

1182

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1922

8040

1.42

41.27

1.2

4.71

3.82

1.48

190

1365

(44790049) Parainfluenza type 3 nucleic acid detection

973

3519

1.63

41.22

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

973

3520

1.63

41.17

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

973

3521

1.63

41.13

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

973

3525

1.63

40.95

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1584

6400

1.47

40.93

5.8

5.7

4380.56

1023.16

iu/ml

0.49

188

957

(3027923) C peptide [Moles/volume] in Serum or Plasma

501

1484

1.99

40.85

1.6

1.33

1.26

nmol/l

0.54

365

1147

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

620

1977

1.85

40.75

1.3

1.4

12.10

12.45

umol/l

0.57

573

1891

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1107

4156

1.57

40.26

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

391

1061

2.17

40.01

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

928

3362

1.63

39.07

1.6

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

217

450

2.84

38.65

1.3

1.8

0.85

1.15

nmol/l

0.87

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2124

9158

1.38

38.19

3.0

3.6

36.42

43.47

mg/l

1.85

1783

7846

(3039162) Centromere protein B Ab [Units/volume] in Serum

1013

3773

1.59

38.12

1.2

1.3

59.12

52.73

u/ml

0.28

228

(3044242) Glucose [Moles/volume] in Arterial blood

435

1258

2.04

37.90

2.3

1.8

8.20

8.10

mmol/l

0.17

435

1258

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1253

4904

1.51

37.85

2.7

2.8

1645.79

7530.03

u/ml

1.19

274

(3034860) Kappa light chains.free [Mass/volume] in Serum

2123

9173

1.37

37.68

3.0

3.6

66.56

68.28

mg/l

0.03

1785

7848

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

580

1863

1.84

37.32

2.8

2.5

0.76

0.66

e9/l

2.26

558

1787

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

295

731

2.38

37.20

4.5

2.7

10.27

10.53

kpa

0.65

295

731

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

295

731

2.38

37.20

4.5

2.7

5.03

4.91

kpa

0.91

295

731

(3008116) Ketones [Moles/volume] in Urine by Test strip

227

495

2.70

36.96

1.7

1.3

0.22

0.24

mmol/l

0.14

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

587

1902

1.82

36.75

1.2

1.1

1.04

2.25

0.55

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

789

2793

1.67

36.36

1.6

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

216

463

2.75

36.30

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2317

10215

1.35

36.16

1.6

7.43

4.13

iu/ml

0.19

414

1819

(3013247) Albumin in CSF/Albumin in Serum or Plasma

247

571

2.55

35.97

1.1

6.48

7.39

mg/g

1.18

238

548

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

534

1693

1.86

35.81

2.3

2.0

98.31

98.05

0.05

505

1582

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

305

782

2.30

35.71

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2086

9083

1.36

35.27

3.7

3.3

1.50

1.49

mg/l

0.26

1930

8373

(3039000) Anion gap in Blood by calculation

1317

5302

1.47

34.70

7.9

6.6

11.34

11.14

mmol/l

1.19

1206

4777

(3018572) Chloride [Moles/volume] in Blood

1317

5303

1.47

34.67

7.9

6.6

104.75

105.27

mmol/l

3.17

1206

4780

(3000475) Leukocytes [#/volume] in Synovial fluid

1677

7074

1.40

34.35

1.6

11382.88

12802.53

e6/l

0.74

1153

5114

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1205

4775

1.49

34.34

1.3

1.2

3.54

4.00

u/ml

0.69

566

2280

(40768800) Prostate Pathology biopsy report

592

5864

0.59

34.25

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

135

224

3.55

34.15

2.3

3.5

41.19

41.37

umol/l

0.03

116

187

(3010838) Calcium [Moles/time] in 24 hour Urine

1312

5300

1.46

33.98

1.8

2.0

5.02

5.21

mmol/24h

0.90

1167

4804

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

928

3507

1.56

32.89

1.6

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

672

2345

1.69

32.72

1.2

107.84

112.60

pmol/l

1.51

672

2345

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

45238

257334

1.13

32.63

27.3

16.9

332.41

332.76

g/l

12.73

45008

255899

(3022621) pH of Urine by Test strip

4884

23928

1.22

32.33

2.8

2.4

6.12

6.07

3.49

3234

15434

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2011

8832

1.35

32.18

3.5

3.1

0.34

0.35

iu/ml

0.22

1090

4840

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1133

4505

1.49

31.79

1.1

119.95

117.23

1.90

1034

4102

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1171

4688

1.48

31.76

1.1

—

(3017569) Oxygen content in Arterial blood

427

1310

1.92

31.67

2.4

2.1

16.30

15.86

1.82

427

1310

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1866

8129

1.36

31.46

2.9

3.5

2.79

6.42

ratio

1.50

1001

4674

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1471

6160

1.41

31.43

1.5

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

497

1610

1.82

31.23

1.9

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

226

537

2.48

31.23

1.8

2.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

519

1708

1.79

31.00

1.4

1.6

7.58

8.36

ug/l

0.49

476

1554

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

298

808

2.17

30.71

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

244

607

2.37

30.63

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

702

2525

1.64

30.52

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

660

2338

1.67

30.43

1.2

153.40

210.45

titre

1.02

103

382

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

713

2580

1.63

30.29

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1291

5319

1.43

30.19

1.3

77.27

147.71

titre

1.42

109

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

780

2890

1.59

30.11

1.2

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

657

2332

1.66

30.07

1.2

269.47

213.03

titre

0.21

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

799

2979

1.58

30.05

1.2

57.23

62.38

u/l

1.77

701

2639

(3023419) Bacteria identified in Sputum by Culture

896

3435

1.54

29.86

2.6

—

(44813793) Dust mix specific IgE antibody measurement

613

2145

1.69

29.60

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1276

5271

1.43

29.43

1.3

312.66

298.77

titre

0.07

399

(3018333) Ribosomal P Ab [Presence] in Serum

654

2334

1.65

29.34

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

245

623

2.32

29.34

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

671

2412

1.64

29.27

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

709

2588

1.62

29.11

1.7

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1213

4979

1.44

28.96

1.2

2.83

3.79

u/ml

1.26

447

1931

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

686

2490

1.63

28.81

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

651

2335

1.64

28.66

3.0

2.7

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

686

2494

1.62

28.63

1.2

—

(40768443) Skin Pathology biopsy report

2909

13659

1.26

28.38

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

664

2402

1.63

28.28

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

551

1900

1.71

28.10

2.7

2.4

526.48

529.44

e6/l

0.04

444

1517

(3051651) Icteric interference index of Serum or Plasma

443

1432

1.82

28.10

4.1

3.9

0.76

0.92

index

2.19

431

1396

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

686

2515

1.61

27.71

4.0

3.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

474

1579

1.77

27.27

1.4

—

(3011048) Pyruvate [Moles/volume] in Blood

108

4.41

27.11

1.4

86.58

69.82

umol/l

2.94

101

(3002079) Sodium [Moles/time] in 24 hour Urine

420

1351

1.83

27.08

1.2

1.3

161.21

159.87

mmol/24h

0.10

420

1351

(21494815) CD4 cells/Lymphocytes in Specimen

686

2533

1.60

26.93

2.4

2.1

40.24

38.26

2.72

674

2487

(4195642) Thrombophilia screening test

1098

4498

1.44

26.53

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

465

1555

1.76

26.42

1.4

—

(3011412) CD3 cells [#/volume] in Blood

729

2753

1.56

26.04

2.6

2.3

1315.89

1171.60

e6/l

2.38

633

2419

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

558

1976

1.66

25.86

2.8

2.6

224.61

232.22

e6/l

0.40

469

1667

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1429

6163

1.37

25.72

2.4

117.90

102.59

ug/min

0.51

832

3734

(3004616) Nuclear Ab [Presence] in Serum

944

3784

1.47

25.54

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1091

4499

1.43

25.46

2.0

2.2

6.72

6.52

umol/l

0.10

800

3300

(3051611) Lipemic interference index of Serum or Plasma

688

2579

1.57

25.38

3.8

3.4

14.77

13.42

index

1.65

432

1397

(3034988) Calcium [Moles/volume] in Capillary blood

163

366

2.62

25.31

1.8

2.0

1.18

mmol/l

0.32

152

352

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

621

2274

1.61

25.26

1.6

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

621

2274

1.61

25.26

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

621

2274

1.61

25.26

1.6

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1120

4655

1.42

25.04

1.4

1.5

17.24

13.08

u/ml

0.29

101

(3035715) Granulocytes [#/volume] in Blood

1285

5484

1.38

24.67

3.3

4.17

4.04

e9/l

1.23

1280

5474

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

419

1390

1.78

24.51

1.3

—

(3001556) Androgen free Index in Serum or Plasma

125

247

2.98

24.39

1.4

1.2

—

(4146454) Self-monitoring of blood glucose

743

2861

1.53

24.38

2.7

2.8

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

971

3955

1.45

24.23

2.7

3.0

150.29

612.72

u/ml

1.52

958

3911

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

322

986

1.92

24.17

1.3

1.2

110.30

110.37

0.01

290

894

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

120

233

3.03

24.11

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

175

418

2.46

24.07

1.5

1.3

61.26

99.69

ng/l

1.03

101

289

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

862

3437

1.48

23.98

1.1

97.07

96.94

0.05

807

3235

(3028717) Thiamine [Mass/volume] in Blood

142

306

2.73

23.84

1.2

64.65

63.06

ug/l

0.36

142

306

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

341

1070

1.88

23.82

1.3

1.2

0.31

0.30

g/l

2.22

273

857

(4034850) Laboratory test

1854

8413

1.30

23.68

11.8

9.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

381

1247

1.80

23.33

1.1

9.27

10.37

u/ml

0.24

210

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

172

3.35

23.04

1.5

1.3

15.34

11.93

pmol/l

0.41

138

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

474

1660

1.68

22.97

1.2

1.3

27.26

25.37

u/l

0.27

405

1415

(4268621) Lupus anticoagulant assay

856

3443

1.47

22.82

2.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

484

1714

1.66

22.51

1.2

1.3

98.95

90.63

u/l

0.76

422

1483

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

552

2022

1.61

22.49

1.5

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

164

393

2.45

22.45

1.5

1.3

0.26

0.24

nmol/l

0.19

119

273

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

313

975

1.89

22.39

3.0

2.8

0.61

mmol/l

0.85

313

975

(3035320) C reactive protein [Mass/volume] in Body fluid

600

2245

1.58

22.39

3.2

2.4

24.16

29.31

mg/l

2.54

414

1625

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

159

378

2.47

22.13

1.9

2.0

1.19

mmol/l

0.09

149

365

(3021788) Differential panel - Synovial fluid

1259

5465

1.36

21.82

1.6

1.5

1.00

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

350

1145

1.80

21.52

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

350

1145

1.80

21.52

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1645

7446

1.31

21.43

1.1

2.01

2.21

u/ml

0.32

918

3852

(3037756) Immunofixation for Serum or Plasma

1264

5508

1.36

21.38

1.5

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

469

1672

1.65

21.30

3.0

2.7

41.13

38.80

1.76

248

918

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

149

350

2.50

21.27

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

303

953

1.87

21.09

2.2

61.01

60.51

ug/l

0.03

297

931

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

782

3149

1.46

20.78

1.2

51.87

45.52

u/ml

0.21

165

(3035947) Staphylolysin Ab [Units/volume] in Serum

388

1325

1.72

20.65

1.1

3.58

4.01

iu/ml

0.32

103

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

209

581

2.12

20.47

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

169

430

2.31

20.40

1.7

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1685

7704

1.29

20.38

1.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

117

249

2.76

20.18

2.0

1.7

1.30

1.36

umol/l

0.70

169

(3028679) Herpes simplex virus Ab [Presence] in Serum

479

1742

1.62

20.16

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

132

303

2.56

19.77

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

343

1146

1.76

19.72

1.1

573.60

352.37

ng/l

0.20

333

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

318

1039

1.80

19.68

1.0

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

525

1968

1.57

19.52

2.9

3.6

113.40

157.85

nmol/l

1.68

511

1948

(37208534) Antinuclear antibody arbitrary concentration in serum

297

954

1.83

19.42

1.1

—

(1175426) CD3 cells/Lymphocytes in Blood

582

2237

1.53

19.38

2.3

2.0

74.71

72.33

3.66

556

2155

(3004809) Band form neutrophils/Leukocytes in Blood

1076

4646

1.37

19.34

3.1

3.5

1.30

1.60

2.40

969

4183

(3003888) Timothy IgE Ab [Units/volume] in Serum

1438

6483

1.31

19.33

1.1

5.12

5.22

u/ml

0.09

788

3395

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

356

1211

1.73

19.26

1.1

0.08

0.55

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

177

472

2.21

19.22

1.1

0.82

3.78

umol/24h

0.49

238

(3026250) Tacrolimus [Mass/volume] in Blood

382

1329

1.69

19.07

43.6

41.3

7.28

7.27

ug/l

0.05

353

1206

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

422

1510

1.65

18.97

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

927

7436

0.73

18.89

1.4

1.5

59.27

60.33

ug/l

0.29

927

7436

(40760888) Immunoglobulin light chains.free panel - Serum

1351

6060

1.32

18.85

3.0

3.6

—

286.02

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

559

2145

1.54

18.78

2.2

1.9

13.59

15.48

4.37

543

2085

(3006245) CD3-CD19+ cells/cells in Blood

331

1112

1.75

18.71

2.5

2.1

8.76

9.90

0.94

310

1027

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1375

6199

1.31

18.50

1.1

1.02

1.01

u/ml

0.03

640

2686

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

163

428

2.24

18.38

1.6

5.62

6.86

nmol/l

0.67

155

413

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

134

322

2.45

18.35

2.1

2.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

559

2160

1.52

18.21

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

581

2265

1.51

18.17

1.2

82.08

79.34

0.41

153

(3017354) Segmented neutrophils/Leukocytes in Blood

732

2990

1.44

18.14

2.8

3.6

57.33

57.31

0.01

634

2595

(3006270) Folate [Moles/volume] in Blood

508

1924

1.56

18.11

1.2

1.1

367.94

378.80

nmol/l

0.52

438

1657

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

145

364

2.34

18.10

2.0

1.9

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

152

390

2.29

18.08

1.1

1.0

85.06

82.46

ug/l

0.26

123

302

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

815

3398

1.41

18.06

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

176

3.01

18.00

1.3

1.2

22.12

14.61

nmol/l

0.45

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

126

297

2.49

17.96

2.3

2.2

0.93

1.38

mmol/l

1.52

207

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

606

2390

1.49

17.94

1.3

2.20

2.00

u/ml

0.16

371

1334

(3000060) B lymphocytes [#/volume] in Blood

262

831

1.86

17.87

2.4

1.9

0.16

0.93

e9/l

1.20

129

359

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

401

1439

1.64

17.86

1.7

1.9

141.91

146.05

0.48

378

1366

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

444

1635

1.60

17.84

1.2

1.3

699.47

526.60

titre

0.19

(3018851) Theophylline [Moles/volume] in Serum or Plasma

157

3.11

17.53

1.6

1.7

48.31

50.41

umol/l

0.20

157

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

316

1069

1.74

17.48

2.3

2.0

28.57

29.59

0.65

300

1011

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

434

1598

1.60

17.46

1.2

1.3

57.00

74.65

titre

0.50

114

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

289

964

1.76

16.80

1.1

93.54

89.87

1.06

127

476

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

653

2651

1.45

16.76

1.2

71.85

66.66

u/ml

0.13

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

167

465

2.11

16.41

1.2

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

841

3589

1.38

16.33

2.0

2.3

32.37

32.51

0.38

836

3571

(3000012) Reticulocyte production index

880

3784

1.37

16.32

2.0

2.2

0.90

0.92

0.26

590

2563

(3014148) Varicella zoster virus Ab [Titer] in Serum

1017

4473

1.34

16.31

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

346

1226

1.66

16.24

4.4

4.8

649.79

2991.87

mg/l

2.03

250

877

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

229

2.62

16.05

1.0

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

467

1787

1.54

15.98

2.5

2.7

819.39

1077.17

u/ml

1.49

462

1765

(3001964) Herpes simplex virus Ag [Presence] in Specimen

236

756

1.84

15.69

1.5

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

652

2681

1.43

15.68

4.1

5.6

47.79

111.27

u/ml

4.34

195

954

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1339

6167

1.28

15.41

1.1

1.79

1.87

u/ml

0.12

753

2943

(3042631) Mycobacterium sp identified in Specimen

817

3509

1.37

15.30

2.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2769

19082

0.85

15.17

1.5

1.6

1031.02

1015.28

mu/l

0.24

2253

16311

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

488

1909

1.51

15.12

1.3

1.5

25.31

23.89

u/ml

0.20

314

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1202

5474

1.30

15.10

1.1

24.21

14.85

au/ml

2.16

234

1664

(3036603) Volume of Urine

565

2278

1.46

15.09

1.6

1.7

2229.57

1948.09

4.34

556

2225

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

287

988

1.71

15.03

1.2

114.08

107.07

1.94

267

899

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

276

954

1.70

14.27

1.1

95.17

90.15

1.04

123

481

(3008037) Lactate [Moles/volume] in Venous blood

1361

6348

1.27

14.17

3.7

2.9

1.53

1.54

mmol/l

0.08

1325

6195

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

183

558

1.93

14.17

1.3

1.2

430.36

283.30

pmol/l

0.80

119

434

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1298

9568

0.79

14.16

1.5

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

131

3.05

14.04

1.3

1.2

—

(3002619) Bacteria identified in Specimen by Culture

216

699

1.82

13.97

1.3

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

556

2270

1.44

13.96

1.2

56.60

55.54

u/ml

0.02

150

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

426

1652

1.52

13.80

1.6

7.78

6.79

u/l

0.58

326

1341

(3020491) Glucose [Moles/volume] in Blood

508

2048

1.46

13.63

1.9

1.7

6.96

6.60

mmol/l

1.53

376

1493

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1074

4889

1.30

13.59

1.2

1.3

29.64

33.36

u/l

0.55

949

4268

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

291

1035

1.65

13.57

1.7

2.0

158.61

167.47

0.75

277

976

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

616

4991

0.72

13.53

3.4

2.3

13.21

13.13

1.30

609

4930

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

205

660

1.83

13.50

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

155

454

2.01

13.46

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

639

2694

1.40

13.44

1.2

1.1

—

(3042733) HLA Ab [Presence] in Serum

277

975

1.67

13.44

4.9

5.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

289

1035

1.64

13.14

1.3

1.2

0.73

0.49

g/l

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

198

640

1.82

12.90

1.2

13.60

12.35

pmol/l

0.18

242

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

182

2.62

12.83

2.1

3.3

2.18

2.24

mg/l

0.10

156

(3028433) Virus identified in Specimen by Culture

241

830

1.71

12.70

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

749

3276

1.35

12.60

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1275

5994

1.25

12.47

1.5

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

775

3414

1.34

12.44

1.2

1.1

1.98

2.05

iu/ml

0.03

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

294

1076

1.61

12.31

1.8

1.9

—

(3033942) Copper [Moles/time] in 24 hour Urine

108

3.10

12.14

1.2

1.4

0.94

0.91

umol/24h

0.02

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

380

1481

1.51

12.11

10.0

5.3

751.71

4488.35

u/ml

0.66

112

217

(3044927) Protein electrophoresis panel - Urine

579

2447

1.39

12.07

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

189

616

1.80

12.04

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

280

1020

1.62

11.96

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

163

508

1.89

11.93

1.4

1.3

1.18

mmol/l

0.34

163

508

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

229

2.36

11.88

1.0

1.1

0.06

0.05

u/ml

0.12

229

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

127

364

2.05

11.75

1.2

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

133

2.83

11.72

1.6

1.7

192.42

166.28

ug/g

0.61

118

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

402

1597

1.48

11.70

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

610

2615

1.37

11.69

1.4

103514.37

126365.85

e6/l

0.41

405

1727

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

233

815

1.68

11.65

3.3

3.1

1.90

1.83

ratio

0.27

209

754

(3010503) CD19 cells [#/volume] in Blood

430

1736

1.46

11.55

2.8

2.5

244.05

351.63

e6/l

0.55

416

1695

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

402

1604

1.48

11.47

1.2

1.1

82.12

80.91

u/l

0.10

348

1437

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

962

4423

1.28

11.36

1.1

2.10

2.83

2.04

115

850

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

108

295

2.15

11.31

1.3

1.4

43.09

54.24

1.18

156

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

132

391

1.98

11.21

2.4

2.5

—

(3000034) Microalbumin [Mass/volume] in Urine

532

2246

1.39

11.20

3.1

3.0

53.02

54.79

mg/l

0.05

386

1610

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

211

2.37

11.08

1.6

1.5

2.07

1.88

mg/l

0.12

129

(3045683) HLA typing for celiac disease panel - Blood or Tissue

462

1907

1.43

11.06

1.0

—

(40768441) Liver Pathology biopsy report

518

2183

1.40

11.03

1.5

1.4

—

(3004451) EKG impression Narrative

380

1513

1.48

10.98

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

186

622

1.76

10.94

1.1

1.2

93.51

87.99

0.54

186

(37021550) Renin [Units/volume] in Plasma --upright

157

499

1.85

10.88

1.3

81.55

67.15

mu/l

0.34

115

384

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

396

1597

1.46

10.74

1.2

1.1

22.72

21.22

u/l

0.16

346

1430

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

195

665

1.72

10.73

1.1

1.3

111.68

105.50

1.88

181

630

(3027231) Wheat IgE Ab [Units/volume] in Serum

183

613

1.76

10.71

1.1

4.21

3.38

u/ml

0.09

157

536

(3010370) Gastrin [Moles/volume] in Serum or Plasma

141

435

1.91

10.69

1.8

68.64

50.83

pmol/l

0.24

117

365

(3045462) Protein/Creatinine [Ratio] in Urine

111

314

2.08

10.68

3.3

4.3

31.95

44.15

mg/mmol

0.83

103

283

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

729

3266

1.31

10.50

3.2

3.5

5.48

9.16

nmol/l

0.83

704

3165

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

197

680

1.70

10.40

1.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

193

665

1.71

10.26

1.6

0.37

0.39

ug/l

0.27

143

494

(3051339) Copper [Moles/volume] in Blood

117

2.81

10.21

1.1

1.2

16.77

16.50

umol/l

0.15

(3020876) Protein [Mass/time] in 24 hour Urine

766

3473

1.30

10.13

2.3

2.5

1.38

1.24

g/24h

0.64

433

2147

(3006576) Bicarbonate [Moles/volume] in Blood

226

817

1.63

10.05

5.8

6.6

25.13

25.04

mmol/l

0.11

209

735

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

113

330

2.01

10.03

1.4

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

115

2.81

10.03

1.0

0.21

0.11

u/ml

0.41

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

543

2346

1.36

10.01

1.1

8.39

7.92

iu/ml

0.15

110

687

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3091

16046

1.14

9.89

2.9

3.5

57.81

50.39

u/ml

0.31

2974

15564

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

321

1265

1.49

9.82

1.1

100.47

96.09

1.62

250

1004

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

114

337

1.99

9.80

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

173

2.41

9.69

1.2

1.1

7.34

9.25

u/l

0.50

173

(3010375) cycloSPORINE [Mass/volume] in Blood

312

1226

1.50

9.68

30.5

30.1

117.08

115.87

ug/l

0.06

245

1030

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

159

528

1.77

9.64

1.1

2.02

3.75

u/ml

0.74

110

332

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

207

2.27

9.58

1.6

1.5

0.55

0.99

mg/l

0.82

135

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

207

2.27

9.58

1.6

1.5

1.94

2.01

mg/l

0.03

132

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

207

2.27

9.58

1.6

1.5

2.04

2.08

mg/l

0.02

147

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

207

2.27

9.58

1.6

1.5

1.99

1.68

mg/l

0.18

120

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

207

2.27

9.58

1.6

1.5

2.00

2.57

mg/l

0.41

136

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

207

2.27

9.58

1.6

1.5

1.89

2.92

mg/l

0.88

146

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

207

2.27

9.58

1.6

1.5

4.33

4.10

mg/l

0.09

128

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

207

2.27

9.58

1.6

1.5

1.79

1.86

mg/l

0.05

145

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

207

2.27

9.58

1.6

1.5

1.22

1.53

mg/l

0.22

119

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

182

630

1.70

9.56

1.1

77.92

76.64

0.09

180

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

804

3698

1.28

9.56

2.5

30.85

27.01

iu/ml

0.34

351

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

153

2.50

9.52

1.1

46.08

100.80

u/l

0.74

127

(3000330) Specific gravity of Urine by Test strip

2714

14013

1.14

9.42

3.6

3.2

1.02

ratio

2.00

2402

12571

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

291

1136

1.51

9.34

1.2

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

104

303

2.02

9.33

1.1

—

(4015189) Microbial culture of sputum

176

608

1.70

9.33

2.8

2.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

733

5481

0.78

9.20

1.3

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.70

8.81

2.9

3.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

125

397

1.85

8.79

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

212

784

1.59

8.68

1.7

9.47

9.14

ug/l

0.47

212

784

(3012494) Peanut IgE Ab [Units/volume] in Serum

218

813

1.58

8.62

1.1

1.78

3.95

u/ml

1.26

127

458

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

438

1876

1.37

8.60

1.1

1.2

1.07

1.06

ratio

0.15

363

1564

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

106

2.72

8.47

1.2

1.1

701.46

330.91

u/l

0.62

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

367

1533

1.41

8.37

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

142

2.44

8.32

1.2

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

329

1349

1.43

8.32

1.1

1.2

22.50

11.63

u/ml

0.40

142

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

338

1395

1.43

8.25

1.6

1.7

1.86

2.98

u/field

1.70

250

996

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

142

479

1.74

8.24

2.8

38.37

53.77

mg/l

0.68

104

(3023487) Leukocytes [#/volume] in Peritoneal fluid

240

926

1.52

8.20

2.4

1.8

3220.34

3218.69

e6/l

0.00

154

607

(3024263) Appearance of Synovial fluid

327

1344

1.43

8.17

1.6

1.8

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

239

2.07

8.08

1.1

1.75

3.28

umol/24h

0.50

239

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

346

1440

1.41

8.08

1.8

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

346

1440

1.41

8.08

1.8

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

346

1440

1.41

8.08

1.8

1.9

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

208

2.15

8.06

1.2

1.1

0.62

0.56

iu/ml

0.10

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

264

1045

1.49

8.01

1.9

1.7

51959.29

18734.73

u/ml

0.40

148

(3047007) Chlamydophila sp Ab [Presence] in Serum

980

4712

1.23

8.00

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

217

2.11

7.95

1.4

1.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

131

2.47

7.94

1.1

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

345

1441

1.41

7.90

1.8

1.9

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

137

464

1.74

7.87

2.7

2.5

7.16

7.44

mmol/l

0.31

279

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

114

2.58

7.87

1.6

1.5

0.00

0.16

u/l

1.02

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

400

1716

1.37

7.83

1.5

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

379

1612

1.38

7.82

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

669

3090

1.27

7.79

1.3

1.4

9.43

8.12

mmol/l

9.35

638

2948

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1128

5522

1.20

7.69

1.1

5.17

3.63

u/ml

1.26

603

2677

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

159

2.29

7.67

1.3

1.5

43.97

36.80

0.56

112

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

3.12

7.64

1.1

1.2

218.30

357.52

pmol/l

0.90

(3002331) Protein [Mass/volume] in Peritoneal fluid

159

566

1.65

7.64

1.4

148.22

37.79

g/l

0.42

110

450

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1466

7354

1.18

7.58

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

198

2.14

7.57

1.3

1.2

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

138

2.38

7.56

1.3

1.6

12.54

13.23

0.07

105

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

258

1.98

7.53

1.2

1.1

1.88

1.77

iu/ml

0.19

136

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

256

1021

1.47

7.52

2.0

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

258

1031

1.47

7.51

2.0

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

256

1022

1.47

7.49

2.0

2.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

107

2.58

7.44

1.0

0.15

0.04

u/ml

0.76

(3013762) Body weight Measured

2.94

7.37

1.1

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

100

314

1.87

7.36

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

124

417

1.75

7.33

1.2

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

120

400

1.76

7.31

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1066

5218

1.20

7.30

1.1

6.19

4.37

u/ml

1.26

520

2280

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

141

2.33

7.23

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

953

4621

1.21

7.21

1.1

2.44

2.96

eliau/ml

1.14

355

2392

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.98

7.15

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

142

2.32

7.13

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

105

339

1.82

7.11

1.6

1.5

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

117

2.46

7.08

1.2

1.3

0.59

1.78

1.62

(44806420) Estimation of glomerular filtration rate

510

3850

0.78

7.05

2.4

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

576

2649

1.28

7.00

1.5

1.6

28.96

33.62

2.15

337

1651

(3024932) HLA-DR beta [Type]

230

913

1.48

6.96

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

287

1.88

6.93

1.1

—

(3012565) Volume of 24 hour Urine

332

1412

1.38

6.92

2.0

2.2

1968.35

2008.78

0.24

304

1282

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

3.55

6.89

1.1

1.0

0.03

0.12

u/ml

0.46

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

106

347

1.80

6.89

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

206

802

1.51

6.85

2.1

1.8

9641.91

13914.10

e6/l

0.35

104

402

(3018133) Calcium [Moles/volume] in Urine

147

530

1.63

6.79

1.7

1.9

2.60

2.82

mmol/l

0.62

138

486

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2011

10420

1.14

6.73

3.2

3.8

374.42

1591.92

u/ml

3.55

1704

9048

(3026692) Albumin [Mass/volume] in Peritoneal fluid

172

646

1.57

6.72

1.6

1.2

11.69

14.46

g/l

3.35

121

508

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

169

2.16

6.71

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

233

1.97

6.67

1.2

1.1

—

(3002256) Pathology report gross observation

7462

41222

1.07

6.64

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

254

1.92

6.64

1.0

1.1

442.94

336.30

u/ml

0.40

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

246

1.94

6.62

1.0

0.15

0.93

u/ml

1.17

169

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1026

5064

1.19

6.48

1.1

1.2

1.26

1.08

0.19

261

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

264

1093

1.42

6.46

2.6

2.8

155.39

140.52

au/ml

0.19

150

(3024471) HLA-A [Type]

232

938

1.45

6.44

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

365

1597

1.34

6.41

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

948

4652

1.20

6.39

1.1

0.39

0.31

u/ml

0.34

338

1328

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

5359

29292

1.08

6.34

3.6

4.5

26.39

26.15

ug/l

0.01

4293

23453

(3006571) Granulocytes/Leukocytes in Synovial fluid

738

3539

1.23

6.29

1.5

1.6

57.87

55.30

0.89

446

2260

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.32

6.29

1.0

1.1

—

(44806071) Cardiolipin IgM antibody measurement

116

403

1.69

6.20

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

175

2.08

6.19

1.5

1.6

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

259

1080

1.41

6.12

1.1

1.0

9.19

10.99

u/ml

0.66

163

721

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.62

6.09

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

165

2.10

6.04

1.5

1.6

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.94

6.03

1.0

0.17

0.62

u/ml

0.83

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

318

1376

1.36

6.03

1.4

1.5

—

(40768446) Kidney Pathology biopsy report

294

1259

1.37

5.95

1.7

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

484

2229

1.28

5.91

1.8

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

317

1376

1.35

5.90

1.4

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

294

1261

1.37

5.90

3.7

4.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

114

2.32

5.81

1.3

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

188

2.00

5.79

1.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

281

1203

1.37

5.72

1.6

1.4

0.52

e9/l

0.04

281

1203

(40757373) Influenza virus identified in Isolate

124

449

1.62

5.71

1.7

1.6

—

(3034426) Prothrombin time (PT)

230

952

1.42

5.70

1.2

28.16

28.04

0.11

230

952

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

542

2546

1.25

5.64

2.2

1.8

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

112

397

1.66

5.61

1.5

1.6

6.41

281931.55

nmol/l

2.77

343

(3038177) Helicobacter pylori Ab [Presence] in Serum

1072

5387

1.17

5.56

1.2

—

(3016228) CD19 cells/cells in Blood

268

1145

1.38

5.54

2.1

2.0

8.99

8.40

0.38

260

1123

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

2.69

5.54

1.0

7733.13

10087.50

ng/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

235

982

1.41

5.53

1.5

1.4

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.40

5.53

1.0

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.40

5.53

1.0

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

300

1306

1.35

5.52

2.5

2.4

22.96

232.24

ug/l

1.80

281

1253

(3003694) ABO and Rh group [Type] in Blood

16409

93164

1.05

5.49

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

272

1.79

5.47

1.0

0.58

1.61

u/ml

0.87

207

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.37

5.45

1.3

1.5

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

7.64

5.45

1.1

1.0

17.85

20.40

umol/l

—

(3033099) Centromere Ab [Titer] in Serum

189

761

1.46

5.44

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

134

501

1.57

5.44

5.5

6.1

5331.67

8410.27

iu/ml

—

(40762365) Oxygen content in Arterial blood by calculation

107

378

1.66

5.44

4.0

2.8

14.48

14.80

ml/dl

0.54

356

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

287

1245

1.36

5.41

3.5

8.33

8.72

mg/l

0.40

228

1001

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

308

1.74

5.39

1.0

0.41

0.25

u/ml

0.17

183

(3017704) Immunofixation for Urine

322

1423

1.33

5.37

1.5

1.7

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

117

425

1.62

5.35

1.0

0.21

0.29

u/ml

0.18

269

(3033086) Enterovirus Ab [Titer] in Serum

2.53

5.27

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

172

685

1.48

5.25

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

283

1233

1.35

5.21

2.2

2.1

69.64

81.26

ug/min

0.18

272

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

238

1.83

5.20

1.2

1.1

87.35

97.61

titre

0.64

238

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

131

494

1.56

5.15

1.1

34.43

28.67

iu/ml

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

153

2.04

5.07

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

550

2623

1.23

5.05

1.4

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.63

5.03

1.0

209.50

180.67

pmol/l

0.28

(3016750) Collection duration of Urine

338

1523

1.31

4.96

2.3

507.64

497.27

min

1.21

252

1149

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

109

398

1.61

4.92

2.1

1.9

—

(3017400) Magnesium [Moles/volume] in Urine

2.88

4.91

1.0

1.1

2.88

2.85

mmol/l

0.02

(3012898) Urea [Moles/volume] in Urine

287

1.72

4.86

1.7

1.5

157.34

173.21

mmol/l

0.55

253

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

448

2102

1.25

4.79

1.9

2.35

3.08

u/field

0.28

253

1155

(21494890) Protein electrophoresis panel - 24 hour Urine

592

2864

1.22

4.76

1.9

2.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

316

1.67

4.74

1.1

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

182

749

1.43

4.74

1.4

53.60

53.27

0.04

151

651

(3044007) Cell count panel - Peritoneal fluid

192

798

1.41

4.73

2.3

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1185

6082

1.15

4.71

1.8

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1889

12309

0.90

4.70

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

134

2.06

4.67

1.1

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

155

1.97

4.60

1.3

1.2

33.63

22.00

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

139

2.03

4.59

1.1

1.12

1.16

u/field

0.18

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

172

1.91

4.56

1.0

13.96

16.21

u/ml

0.15

138

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.94

4.49

1.4

1.3

71.17

56.47

e6/l

0.09

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

668

3290

1.19

4.48

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

221

954

1.36

4.39

1.1

3.50

5.66

u/ml

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

768

0.62

4.37

1.3

1.2

60.83

68.28

ug/l

0.87

768

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

411

1933

1.25

4.35

1.4

12.31

13.05

u/l

1.43

401

1870

(3016031) Almond IgE Ab [Units/volume] in Serum

231

1.76

4.33

1.0

0.54

0.59

u/ml

0.06

123

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

363

1685

1.27

4.30

1.4

5.75

5.54

mmol/l

2.13

340

1593

(3020393) Adenovirus Ag [Presence] in Stool

276

1.68

4.28

1.1

1.2

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

8.81

4.20

2.2

2.0

—

(3003195) risperiDONE [Mass/volume] in Serum or Plasma

+∞

4.19

1.4

0.0

3.95

—

ug/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

123

484

1.49

4.09

1.2

1.3

230.00

11183.60

u/ml

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

271

1.67

4.08

1.0

0.28

1.56

u/ml

0.91

204

(3036071) Salmonella sp Ab [Titer] in Serum

221

967

1.34

4.06

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

240

1064

1.33

4.04

2.0

40.16

40.53

g/l

0.42

240

1064

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

980

5025

1.15

4.02

1.3

3.03

3.62

ug/l

2.26

875

4510

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

112

972

0.68

4.02

6.4

6.5

9.55

8.69

0.92

112

972

(40761995) Spermatozoa Progressive [#/volume] in Semen

112

972

0.68

4.02

3.2

3.3

42.28

45.29

0.84

112

972

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

106

407

1.53

3.96

1.1

1.3

37.64

41.03

mg/l

0.33

346

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

141

1.92

3.83

13.1

9.9

568.94

225.70

e6/l

0.51

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.26

3.77

1.0

1.1

0.20

0.21

g/l

0.37

(42529582) MDA5 Ab [Presence] in Serum by Line blot

183

788

1.37

3.76

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

183

788

1.37

3.76

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

183

788

1.37

3.76

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

183

788

1.37

3.76

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

151

1.87

3.72

1.3

1.4

23.15

21.96

mmol/l

0.66

101

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.68

3.71

1.4

3.2

5.51

1.79

mu/l

0.81

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

147

612

1.41

3.69

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

160

1.84

3.68

2.4

1.8

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

400

2863

0.82

3.67

1.5

1.6

8.12

7.60

mmol/l

4.56

382

2748

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

182

1.78

3.65

1.0

0.27

0.10

u/ml

0.30

182

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

200

1.73

3.61

1.2

1.3

110.17

109.00

ug/l

0.02

127

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

209

1.71

3.60

1.5

1.3

1.22

1.53

ml/s/173m2

0.32

132

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

154

1.83

3.52

1.1

2.96

2.89

u/l

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

193

1.74

3.52

1.6

1.3

18.14

15.08

pmol/l

0.25

167

(3024316) Viscosity of Plasma

129

1.91

3.51

1.7

2.0

1.62

1.55

mpas

0.26

(3049233) Organic acids panel - Urine

5.34

3.50

1.1

1.0

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

338

1.53

3.35

1.0

0.76

2.51

u/ml

0.46

155

(3027456) Digoxin [Moles/volume] in Serum or Plasma

922

4775

1.14

3.34

3.4

3.2

0.82

0.81

nmol/l

0.28

722

3854

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.52

3.33

1.2

1.0

2.67

3.00

0.22

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

179

1.74

3.32

1.0

1.09

2.92

u/ml

0.70

145

(3036670) Protein [Mass/volume] in Synovial fluid

184

811

1.33

3.31

1.3

1.2

38.85

40.76

g/l

1.06

430

(37019676) Renin [Units/volume] in Plasma --supine

2.71

3.27

1.1

1.0

66.39

58.44

mu/l

0.06

(40759632) Porphyrins [Mass/mass] in Stool

3.64

3.23

1.2

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

146

1.81

3.22

1.2

1.3

1770.03

952.70

u/l

0.26

135

(46235168) Fasting glucose [Moles/volume] in Blood

452

0.58

3.19

6.5

1.3

7.98

7.11

mmol/l

0.95

130

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1306

6927

1.11

3.17

1.4

112.39

133.59

pmol/l

1.16

1273

6759

(3025549) Creatine [Moles/time] in 24 hour Urine

204

1.67

3.17

1.7

1.4

—

14.60

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

107

434

1.45

3.16

5.7

5.4

49.67

43.19

ug/min

0.40

330

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

196

1.68

3.12

2.1

3.3

49.56

377.48

pmol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1140

6010

1.12

3.10

3.0

3.7

740.94

1057.45

u/ml

0.46

1020

5455

(3043410) Blood group antigens tested for on Red Blood Cells

173

764

1.33

3.10

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

201

907

1.30

3.10

2.1

1.9

1.80

ratio

0.01

192

881

(3022229) Phosphate [Moles/volume] in Urine

144

1.80

3.08

1.8

1.9

18.04

18.76

mmol/l

0.12

119

(3042628) Porphyrins [Moles/volume] in Urine

5.87

3.07

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.02

3.05

1.0

0.04

0.13

u/ml

0.46

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

333

1.50

2.99

1.0

0.18

0.67

u/ml

0.69

152

(3038515) Glucose [Moles/volume] in Venous blood

1024

5388

1.12

2.91

4.1

3.1

7.44

7.48

mmol/l

0.16

995

5270

(3004775) Volume in Urine collected for unspecified duration

414

2041

1.19

2.91

2.4

702.86

675.43

0.58

304

1414

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

156

1.73

2.89

1.1

1.2

5.85

4.33

u/ml

0.10

123

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.52

2.88

1.0

0.11

0.21

u/ml

—

(3034891) Synovial lining cells/cells in Synovial fluid

300

1436

1.23

2.86

1.4

1.5

3.55

4.37

0.37

321

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.27

2.85

1.0

2.56

0.78

u/ml

0.35

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

665

3412

1.15

2.84

2.0

29.20

25.39

ug/l

0.46

654

3351

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

240

1123

1.26

2.82

1.0

0.46

0.64

u/ml

0.50

233

1101

(3042951) Complement C1q Ab [Units/volume] in Serum

136

1.77

2.78

1.3

12.43

20.64

u/ml

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

134

582

1.35

2.73

1.1

1.2

—

(3011325) HIV 1+2 Ab [Presence] in Serum

137

1.76

2.72

1.1

1.0

0.09

0.08

0.44

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

391

2717

0.84

2.71

1.4

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

332

1.47

2.69

3.1

2.7

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

151

1.71

2.67

1.5

1.7

0.76

0.69

umol/l

0.33

118

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

250

1185

1.24

2.65

3.4

3.3

1.42

1.30

0.47

250

1185

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.04

2.64

1.0

3.66

3.16

u/ml

0.06

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

319

1.47

2.64

1.0

0.42

1.23

u/ml

0.54

150

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

292

1.49

2.57

2.5

2.2

0.66

0.62

u/field

0.12

292

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

204

1.58

2.52

1.1

14.20

33.77

u/ml

2.21

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

204

1.58

2.52

1.1

24.78

24.28

u/ml

0.02

(3035285) Chloride [Moles/volume] in Venous blood

561

2878

1.15

2.46

2.8

2.2

105.39

105.62

mmol/l

0.52

561

2850

(3041354) Potassium [Moles/volume] in Venous blood

561

2880

1.15

2.44

2.8

2.2

4.01

4.05

mmol/l

1.26

561

2852

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

150

676

1.30

2.42

2.0

2.9

96.61

106.16

ng/l

0.32

345

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

306

1.46

2.42

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

399

1.40

2.41

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

102

434

1.38

2.40

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

138

618

1.31

2.35

2.7

2.6

338.22

480.49

ug/l

0.14

138

618

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

357

1.42

2.34

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

256

1.49

2.32

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2791

17333

0.94

2.29

1.6

—

(3007916) DNA double strand Ab [Titer] in Serum

364

1.40

2.28

1.4

1.3

95.50

148.25

titre

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

324

0.60

2.25

1.1

1.28

1.17

mom

0.36

324

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.93

2.25

7.2

9.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

257

1248

1.21

2.22

2.2

2.1

8.83

9.34

mg/l

0.81

214

1030

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.06

2.22

1.6

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

102

1.79

2.21

1.1

224.52

327.27

nmol/l

1.41

102

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

309

1528

1.19

2.20

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

343

1.40

2.17

1.7

1.8

1.60

1.74

mg/l

0.43

287

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.93

2.16

1.1

1.3

27.77

50.30

umol/24h

0.58

(40762887) Creatinine [Moles/volume] in Blood

190

1.55

2.12

1.5

1.4

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

108

1.74

2.12

5.4

5.9

15.75

18.04

mmol/l

1.47

101

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

144

1.63

2.11

5.5

4.7

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.32

2.09

2.5

3.8

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.32

2.09

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

126

568

1.30

2.08

1.3

1.2

83.66

60.73

mg/l

0.21

388

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2065

11396

1.07

2.07

1.5

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

215

1.50

2.07

1.0

1.1

—

(3000219) Insulin receptor Ab [Presence] in Serum

5.87

2.06

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

117

524

1.31

2.04

6.2

7.7

64.18

73.00

2.69

408

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.74

2.00

1.0

52.71

22.09

umol/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1630

10246

0.93

1.99

1.5

61.01

62.63

ug/l

0.65

1317

8578

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

209

0.53

1.99

1.1

1.3

—

(3019174) dRVVT (LA screen)

246

1.46

1.98

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

115

1.69

1.98

3.4

3.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

543

2833

1.13

1.92

4.3

4.0

60.40

54.93

u/ml

0.13

535

2807

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

116

1.67

1.92

1.1

1.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.75

1.91

1.1

1.06

0.93

u/field

0.37

(3032641) Amino acids panel - Urine

3.13

1.90

1.4

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

1561

8571

1.07

1.86

1.1

—

(3007147) Virus identified in Stool by Electron microscopy

3.43

1.86

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

359

1.36

1.85

1.2

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

291

1.39

1.80

1.2

1.3

5.29

6.44

mmol/l

0.99

137

(3045177) Copper [Moles/volume] in Urine

2.09

1.79

1.1

1.0

0.22

0.50

umol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

186

1.48

1.72

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

152

722

1.24

1.71

1.2

1.3

41.28

41.49

0.02

104

481

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1269

7995

0.93

1.71

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

807

4337

1.09

1.68

1.3

7.28

7.02

mmol/l

1.76

734

3821

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

1.81

1.63

8.1

9.3

53.50

44.97

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.18

1.62

1.4

1.1

0.92

1.46

0.42

(3000285) Sodium [Moles/volume] in Blood

109

502

1.28

1.61

1.3

1.2

138.10

138.55

mmol/l

0.52

427

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

118

1.59

1.60

9.5

8.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

313

1.35

1.60

1.0

1.1

0.81

6.00

u/ml

0.47

158

(3008536) Aspergillus sp Ab [Presence] in Serum

126

592

1.25

1.59

2.3

2.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

225

1.41

1.55

1.0

1.1

9.33

6.83

u/ml

0.32

132

(3020874) Milk IgE Ab [Units/volume] in Serum

428

2237

1.12

1.55

1.0

1.1

0.96

2.65

u/ml

1.18

178

641

(3033705) Calcium.ionized [Moles/volume] in Venous blood

537

2843

1.11

1.55

2.9

2.2

1.20

mmol/l

0.12

537

2815

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1550

9660

0.94

1.54

1.4

1.5

1.18

1.17

ratio

0.14

879

5863

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

133

632

1.24

1.53

1.2

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

172

1.47

1.52

1.1

—

(3015531) Creatine kinase.macromolecular [Enzymatic activity/volume] in Serum or Plasma

3.67

1.52

1.2

1.0

8.80

0.00

u/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

473

2490

1.12

1.52

1.3

160.68

189.17

pmol/l

1.69

473

2490

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

133

633

1.23

1.51

1.2

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

187

1.45

1.51

4.2

6.2

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

122

0.48

1.50

1.0

0.13

0.90

u/ml

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

133

634

1.23

1.49

1.2

1.1

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

188

928

1.19

1.49

1.7

81.52

129.48

au/ml

1.34

127

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1556

9683

0.94

1.48

1.4

1.5

0.98

0.94

ratio

1.62

884

5884

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1556

9683

0.94

1.48

1.4

1.5

1.23

1.18

ratio

1.39

888

5940

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.72

1.48

1.0

1.1

0.08

0.07

u/ml

0.04

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

369

1.31

1.47

2.9

2.8

51.60

76.49

pmol/l

1.62

325

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.35

1.46

1.1

1.0

—

(3036048) Francisella tularensis Ab [Titer] in Serum

149

722

1.21

1.44

1.1

1.2

168.00

560.00

titre

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

325

1.32

1.42

2.4

2.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

262

1336

1.15

1.41

1.2

1.3

1014.81

1052.61

titre

0.17

287

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

1.40

0.0

1.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

605

3243

1.10

1.39

1.5

4581.37

2390.98

e6/l

1.50

420

2254

(3036005) Urine sediment comments by Light microscopy Narrative

2.30

1.38

1.0

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

435

1.27

1.38

1.7

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

348

1812

1.13

1.38

6.4

7.3

62.40

72.64

ug/l

0.07

217

1193

(3020356) Listeria sp identified in Specimen by Organism specific culture

196

1.41

1.37

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

133

0.53

1.37

1.0

0.07

0.44

u/ml

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.68

1.37

1.0

0.08

0.18

u/ml

0.32

(3017958) Strawberry IgE Ab [Units/volume] in Serum

100

1.59

1.36

1.0

0.07

0.16

u/ml

0.45

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.07

1.35

1.1

3142.17

3566.29

titre

0.26

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

153

750

1.20

1.34

1.8

1.9

37.58

33.87

u/l

0.12

140

692

(3005033) Fetal Nuchal fold Thickness US

1255

7829

0.94

1.33

1.5

1.27

1.25

0.44

862

5766

(3035153) Lemon IgE Ab [Units/volume] in Serum

2.71

1.33

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1536

9507

0.95

1.26

1.4

1.5

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

117

1.51

1.24

1.2

1.1

0.04

0.44

mg/l

0.53

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.64

1.23

2.0

2.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

857

4691

1.07

1.23

1.7

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

2.24

1.22

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

267

1.32

1.21

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.62

1.21

2.0

2.2

151640.00

623188.24

u/ml

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

137

1.46

1.21

1.0

1.3

—

438.57

—

(4035726) Immunohistochemistry procedure

4558

26015

1.03

1.18

1.4

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.80

1.18

3.4

4.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1311

8125

0.95

1.16

1.5

1.6

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

431

1.24

1.15

1.5

1.6

109.86

116.63

ug/l

0.23

350

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

250

1294

1.14

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

144

1.43

1.14

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

354

1.26

1.12

2.4

2.6

—

(4211845) Urine protein measurement

278

1452

1.13

1.11

3.0

2.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

201

1.34

1.07

1.3

1.1

—

(3021374) Sirolimus [Mass/volume] in Blood

2.03

1.06

8.8

8.6

7.01

7.60

ug/l

—

(3041184) Isoniazid [Presence] in Urine

2.03

1.06

2.6

2.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

448

1.22

1.03

1.7

1.5

—

(3029612) Listeria sp Ab [Titer] in Serum

1.75

1.03

1.4

1.3

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

285

1.28

1.03

1.6

—

(3006462) Nitrate [Presence] in Urine

252

1317

1.12

1.02

3.1

2.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

531

2884

1.08

1.00

1.5

51993.06

53719.20

e6/l

0.04

290

1613

(3027035) Albumin [Mass/time] in 24 hour Urine

271

1.28

0.99

1.3

136.53

319.39

mg/24h

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

199

1.33

0.99

1.5

1.3

309.56

316.88

umol/24h

0.10

199

(3001686) Cold agglutinin [Titer] in Serum or Plasma

103

504

1.20

0.99

1.2

1.4

63.00

374.65

titre

—

(4133840) Spirometry

129

887

0.85

0.99

1.2

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.57

0.97

1.1

1.0

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.55

0.96

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.61

0.96

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1148

6408

1.05

0.95

4.9

3.7

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

165

846

1.15

0.92

1.4

58.68

63.02

0.83

140

696

(3028468) Fragments [Presence] in Blood by Light microscopy

2.20

0.92

1.0

1.9

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

166

0.67

0.91

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

136

1.38

0.91

1.1

—

(3045788) Cell count panel - Pleural fluid

489

2660

1.08

0.91

1.5

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.56

0.86

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

250

1324

1.11

0.85

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

217

0.73

0.83

2.4

2.5

—

(44786800) Granulocytes/Leukocytes in Body fluid

274

1.24

0.82

1.2

1.3

26.63

24.54

0.16

215

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

387

1.20

0.80

1.2

1.3

6.00

5.79

mmol/l

1.32

387

(40765089) Chromosome analysis panel - Blood by G-banded

221

1168

1.11

0.79

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1076

6032

1.05

0.79

4.3

3.1

24.32

26.82

mg/l

1.49

735

4108

(40768795) Lymph node Pathology biopsy report

496

3118

0.93

0.78

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.76

0.78

1.0

0.03

0.09

u/ml

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.76

0.78

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.76

0.78

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.76

0.78

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.76

0.78

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.76

0.78

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.76

0.78

2.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

240

1.25

0.76

1.1

1.0

0.17

0.71

u/ml

0.63

132

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.87

0.74

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

203

1073

1.11

0.74

1.1

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

663

3678

1.06

0.74

1.5

79.56

33.23

g/l

0.51

606

3344

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.65

0.74

1.9

2.5

—

(3034614) HLA Ag [Interpretation]

1.47

0.73

1.4

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

191

0.74

0.72

2.2

0.72

0.65

ug/l

0.34

191

(3020618) Glucose [Moles/volume] in Synovial fluid

1.39

0.72

1.1

4.97

mmol/l

0.00

(3000690) Aldosterone [Moles/time] in 24 hour Urine

1.96

0.70

1.4

1.1

35.20

37.13

nmol/24h

—

(3027874) Urate [Moles/volume] in Urine

103

1.37

0.69

1.1

1.85

7.15

mmol/l

0.50

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.64

0.66

1.1

4.4

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.64

0.66

1.0

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

114

1.34

0.66

1.2

1.1

—

(3022670) pH of Venous cord blood

1.57

0.64

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.53

0.63

1.0

0.49

0.51

u/ml

0.01

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.63

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.62

0.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

162

1.27

0.62

3.9

3.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

835

4692

1.05

0.61

3.7

29.04

40.81

u/ml

2.72

803

4539

(3023436) Glucagon [Mass/volume] in Serum or Plasma

153

1.27

0.59

1.7

2.0

236.07

201.23

ng/l

0.39

137

(3046861) Legionella sp Ag [Presence] in Urine

190

1.24

0.59

1.1

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.63

0.56

5.5

6.8

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

367

2024

1.07

0.55

1.5

1.4

31.34

35.06

nmol/l

1.33

323

1890

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

305

1.17

0.55

2.9

2.8

1.25

1.29

mg/l

0.08

206

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

135

0.74

0.54

1.2

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.60

0.54

1.5

2.0

9.97

23.39

ng/l

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

166

1.24

0.53

1.6

1.7

0.72

0.57

0.26

130

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.53

0.52

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

483

1.13

0.52

1.5

1.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

506

1.13

0.51

3.6

2.7

1824.76

1508.04

u/l

0.16

452

(4212803) Bone marrow aspirate examination

222

1.19

0.49

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

100

1.29

0.47

1.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.38

0.47

6.1

5.3

0.21

0.24

mmol/l

0.17

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.47

0.47

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.47

0.47

1.1

68.36

66.22

0.14

(3045142) Bone marrow Pathology biopsy report

543

3335

0.96

0.46

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

278

1.16

0.46

1.0

1.1

22.67

21.07

u/l

0.22

179

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.71

0.46

1.1

1.2

38.87

33.60

mg/24h

0.27

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

1.73

0.45

1.2

1.0

0.90

0.86

u/ml

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

136

731

1.09

0.44

1.4

3.29

2.59

0.49

119

613

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

1.63

0.43

1.0

1.2

41.40

30.83

ug/l

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

1.55

0.42

1.0

4.68

2.11

u/ml

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

292

1.15

0.41

1.2

0.07

0.35

u/ml

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.41

0.0

1.7

—

(3001729) Color of Synovial fluid

199

1.18

0.41

1.6

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

124

667

1.09

0.40

1.4

25.81

20.61

1.16

115

597

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

499

0.89

0.40

5.9

6.9

10.52

10.62

0.14

499

(3003740) Influenza virus B Ag [Presence] in Specimen

1097

6623

0.97

0.40

1.1

—

(40758292) HTLV I+II Ab panel - Serum

100

646

0.91

0.39

1.3

1.4

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.36

0.39

1.0

1.1

1164.44

2395.90

titre

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.31

0.38

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

447

0.89

0.38

5.4

8.31

8.34

mmol/l

0.03

447

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

120

1.22

0.37

1.1

1.2

1599.60

5133.71

ng/l

1.66

(3036782) Glucose [Moles/volume] in Pleural fluid

477

2690

1.04

0.37

1.3

6.50

6.28

mmol/l

0.90

438

2533

(3001218) Citrate [Mass/time] in 24 hour Urine

1.34

0.36

1.5

1.3

385.15

399.68

mg/24h

0.07

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

219

1.15

0.35

2.3

2.0

48.21

60.44

1.20

144

(3002523) Influenza virus A Ag [Presence] in Specimen

1100

6624

0.97

0.35

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

118

0.80

0.33

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

149

1.18

0.33

1.2

1.1

—

(40763590) HLA-DQ beta [Type]

122

1.20

0.33

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

199

1.15

0.32

1.6

1.5

—

(21494434) Karyotype in Bone marrow

445

2517

1.04

0.32

1.2

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

101

1.22

0.32

1.3

1.27

1.05

u/field

0.73

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

371

2268

0.96

0.31

1.3

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

385

0.90

0.31

1.3

109.17

234.54

u/l

0.45

277

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

140

1.17

0.30

1.0

1.1

0.01

1.36

u/ml

1.73

140

(3022475) Manganese [Moles/volume] in Blood

173

1.15

0.30

1.1

1.3

0.17

0.16

umol/l

0.54

173

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

212

1.14

0.29

1.1

5.44

20.56

iu/ml

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.26

0.29

1.3

1.2

1.56

2.25

mmol/24h

1.42

(40760409) HLA-A [Type] by High resolution

124

1.18

0.29

1.0

—

(40760410) HLA-B [Type] by High resolution

124

1.18

0.29

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.31

0.29

1.4

1.3

6.94

15.65

u/ml

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.31

0.29

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

308

1.11

0.28

1.4

1.5

—

(40762814) Titanium [Mass/volume] in Blood

443

0.91

0.27

2.6

4.08

3.65

ug/l

0.17

163

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

114

1.19

0.27

1.5

1.2

—

(3013862) HLA-DP [Type]

125

1.17

0.27

1.0

—

(46236302) HLA-C [Type] by High resolution typing

125

1.17

0.27

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

377

2136

1.04

0.27

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.23

0.26

1.1

1.0

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

170

1.14

0.26

2.4

1.9

13.25

18.20

0.39

(3014599) Egg white IgE Ab [Units/volume] in Serum

387

2200

1.03

0.24

1.0

1.67

2.49

u/ml

0.29

122

499

(40758358) Immune stain study

116

1.16

0.23

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

441

2515

1.03

0.23

1.3

526.85

440.99

u/l

0.68

416

2394

(3009992) Blasts/cells in Bone marrow

1.28

0.23

1.2

2.0

17.00

16.09

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

211

1.11

0.23

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

1.19

0.22

1.1

0.04

0.13

g/l

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.19

0.22

1.1

1.0

8.16

12.79

mg/l

—

(3010937) Rubella virus Ab [Presence] in Serum

217

1.11

0.22

1.1

—

(36305197) Thyroglobulin and thyroperoxidase Ab panel - Serum or Plasma

0.00

0.22

0.0

1.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.22

0.0

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

259

1578

0.96

0.22

2.2

3.66

3.77

ug/l

0.06

230

1467

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

5.5

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.21

0.0

8.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

496

0.94

0.21

1.1

12.91

9.10

u/ml

0.32

496

(3018738) Hemoglobin F/Hemoglobin.total in Blood

179

1.12

0.20

3.4

3.2

27.94

11.37

2.05

(3006598) pH of Arterial cord blood

1.24

0.20

1.0

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.24

0.20

1.0

448.20

344.81

umol/l

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

422

2416

1.03

0.19

1.8

4.02

3.76

mg/l

0.45

402

2325

(40768806) Pleura Pathology biopsy report

488

2800

1.02

0.19

1.5

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

141

1.12

0.19

6.6

12.4

109.15

106.11

g/l

0.53

141

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.82

0.18

2.3

1.2

6.36

8.92

mg/l

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

418

2395

1.03

0.18

1.1

20.13

20.11

u/ml

0.00

152

1015

(3047189) Immunofixation for 24 hour Urine

227

1290

1.03

0.17

1.7

1.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

322

1940

0.97

0.16

1.7

1.9

170.65

911.24

pmol/l

1.17

284

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.78

0.16

1.2

79.83

82.92

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

194

1.09

0.15

1.1

0.54

0.81

u/ml

0.29

133

(3029396) Erythrocyte agglutination [Presence] in Blood

183

1111

0.97

0.15

2.8

3.1

—

(4038314) Semen analysis, post vasectomy

289

0.93

0.14

1.2

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

1.20

0.13

1.0

1.1

4.77

4.75

kpa

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

118

720

0.96

0.13

1.2

1.3

285.41

204.47

ug/l

0.18

381

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

336

2016

0.98

0.13

1.2

1.3

14.93

14.28

u/l

0.16

316

1865

(3023383) Lactate [Moles/volume] in Pleural fluid

130

791

0.97

0.13

1.3

4.56

3.32

mmol/l

2.30

120

739

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.17

0.12

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

223

1278

1.02

0.12

1.7

1.6

2698.46

3753.66

titre

1.27

229

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

364

0.95

0.11

1.2

1.5

—

(40765096) Chromosome analysis panel by Banding

141

853

0.97

0.11

1.1

1.2

—

(3014891) Appearance of Pleural fluid

313

1.05

0.10

1.8

1.6

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

264

1581

0.98

0.10

1.2

9.80

9.55

mm/h

0.13

264

1581

(3044416) Complement C4 [Mass/volume] in Pleural fluid

124

1.09

0.10

1.1

1.2

0.10

0.06

g/l

0.52

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.09

0.10

1.2

1.0

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

100

569

1.03

0.09

1.4

30.34

22.96

1.40

475

(3042010) Triglyceride [Moles/volume] in Pleural fluid

430

1.04

0.09

1.2

1.3

1.27

1.32

mmol/l

0.04

282

(3006969) Lambda light chains [Mass/volume] in Urine

1.11

0.09

1.1

0.03

0.09

g/l

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

263

1.05

0.09

1.0

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

154

1.07

0.08

1.1

—

(3035880) pH of Pleural fluid

240

1386

1.02

0.08

1.2

1.3

7.36

7.41

2.38

164

987

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

380

1.04

0.07

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

130

747

1.02

0.07

6.1

8.2

6.03

5.96

kpa

0.40

114

670

(3015076) Soybean IgE Ab [Units/volume] in Serum

344

2045

0.99

0.07

1.0

0.59

0.64

u/ml

0.08

120

426

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.90

0.07

1.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.91

0.07

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

269

0.96

0.06

1.1

1.2

17.73

17.62

g/l

0.03

249

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.10

0.06

1.2

1.1

240.21

266.34

u/ml

0.23

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

119

713

0.98

0.06

1.1

24.67

29.92

iu/ml

0.65

119

713

(3020650) Glucose [Presence] in Urine

200

1158

1.01

0.05

1.6

1.5

0.03

0.04

estimate

0.24

200

1158

(4281824) Cell count and differential, peritoneal fluid

543

3214

0.99

0.05

1.1

—

(3007542) Rye IgE Ab [Units/volume] in Serum

197

1.04

0.05

1.0

1.1

0.56

10.54

u/ml

0.49

(3025577) Chromium [Mass/volume] in Blood

256

1521

0.99

0.05

2.2

2.47

2.37

ug/l

0.10

203

1279

(3007700) Barley IgE Ab [Units/volume] in Serum

174

1.05

0.05

1.0

1.1

0.30

8.70

u/ml

0.51

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.09

0.05

1.3

1.2

21.58

29.44

mg/l

1.16

(3048879) Bone marrow aspiration report

129

746

1.02

0.04

1.9

2.00

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

130

774

0.99

0.03

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

259

1508

1.01

0.03

2.0

1.8

2.52

2.55

u/ml

0.01

431

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

188

0.97

0.02

4.0

5.7

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

300

0.98

0.02

1.4

69.90

71.60

0.13

255

(3041918) Cholesterol [Moles/volume] in Pleural fluid

524

0.99

0.02

1.2

1.70

1.67

mmol/l

0.08

325

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

194

1.03

0.02

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.08

0.02

2.4

2.1

28.20

27.55

0.07

(3003577) Lead [Moles/volume] in Blood

276

0.98

0.02

1.3

1.6

0.46

0.32

umol/l

0.35

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

382

1.01

0.02

1.3

1.4

10.94

12.23

0.14

198

(3038071) Oxygen [Partial pressure] in Mixed venous blood

113

669

0.99

0.01

6.2

8.0

5.68

5.62

kpa

0.09

113

669

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

578

1.01

0.00

2.2

1.7

2.03

3.69

ug/l

1.03

360

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

156

0.98

0.00

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

126

0.98

0.00

1.0

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

391

1.01

0.00

7.6

8.2

0.36

0.40

umol/l

0.23

357

(3006906) Calcium [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

2.50

—

(40760083) Phosphate/Creatinine [Ratio] in Urine

0.00

0.0

3.4

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.8

—

5.63

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.98

-0.00

1.2

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.91

-0.00

1.0

—

(3018291) Platelet Ab [Presence] in Serum

1.00

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: KRA_PSY_MOOD_EXMORE – Mood disorders, excluding more controls

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Mood disorders, excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints